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1 Summary
Epidemiological studies have shown that elevated air pollution levels and
day-to-day variations in air temperature are associated with increases in car-
diovascular events such as arrhythmias, myocardial infarctions, and sudden
cardiac death. Precursors of these events might be acute changes in heart
rate, a reduced heart rate variability (HRV), and changes in the repolariza-
tion of the heart, such as QTc-prolongation as well as changes in T-wave am-
plitude. Furthermore, elevated levels of blood markers of inflammation and
coagulation might also lead to the observed adverse cardiac health outcomes.
There is already a large body of literature with regard to air pollution effects
on HRV parameters and blood markers but the exact biological pathways are
still unclear. Little is known about the association between temperature and
HRV as well as blood markers. Moreover, potential mechanisms how air pol-
lutants and temperature affect repolarization have received less attention.
Researchers have reported that individuals with genetic predispositions or
underlying diseases such as diabetes mellitus type 2 might be more suscepti-
ble to air pollution exposure. Therefore, more comprehensive investigations
in these groups of individuals are necessary in order to gain a better insight
in the biological mechanisms.
In the first publication of this thesis, I examined the effects of air temper-
ature on markers of inflammation and coagulation in men with coronary or
pulmonary disease. A temperature decrease was associated with changes in
several blood biomarkers such as platelet counts, factor VII, fibrinogen, and
C-reactive protein. However, the direction and timing of the relationship
differed between patients with coronary and pulmonary disease. In a second
publication, I observed a prolongation of the QT-interval in association with
elevated levels of particulate matter (PM) in myocardial infarction survivors.
This association was more pronounced in participants with at least one mi-
nor allele of the NFE2L2 single nucleotide polymorphism (SNP) rs2364725
which is believed to be involved in the defense against oxidative stress. Fur-
thermore, I detected immediate T-wave flattening and delayed increases in
T-wave amplitude associated with elevated air pollution levels. The associa-
tion between temperature and the T-wave amplitude was inversely U-shaped
with highest values at 5◦C. In a third study among participants with diabetes
or impaired glucose tolerance (IGT), I detected reduced HRV, predominantly
the standard deviation of normal-to-normal intervals, in association with in-
creases in PM and ultrafine particles. These effects were more pronounced
in participants with IGT. I also observed air pollution effect modifications
by SNPs supposed to influence cardiac rhythm.
In conclusion, this thesis confirms and extends published results on short-
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term air pollution effects on intermediate markers of cardiovascular system.
Furthermore, it is among the first to examine air temperature effects on
blood and ECG parameters. Certain medical conditions as well as certain
genetic profiles seem to make some subpopulations more susceptible to envi-
ronmental stressors. The observed changes in HRV and blood markers might
partly explain the reported associations between environmental conditions
and cardiovascular events.
5
2 Zusammenfassung
Epidemiologische Studien haben gezeigt, dass erhöhte Schadstoffkonzentra-
tionen und Änderungen der Lufttemperatur mit sofortigen und verzögert
auftretenden kardiovaskulären Ereignissen wie Arrhythmien, Herzinfarkten
und plötzlichem Herztod zusammenhängen. Diesen Ereignissen gehen mög-
licherweise eine akute Änderung der Herzfrequenz, eine verminderte Herz-
ratenvariabilität (HRV) und eine Veränderung des Repolarisationvorgangs
des Herzens voraus wie etwa ein Verlängerung des QTc-Intervalls oder Än-
derungen der T-Wellen Amplitude. Darüberhinaus könnten auch erhöhte
Entzündungs- und Gerinnungsmarker im Blut das Risiko für kardiovaskuläre
Ereignisse erhöhen. Es wurden bereits eine Vielzahl von Studien zu Schad-
stoffeffekten auf HRV- und Blutparameter veröffentlicht. Allerdings sind die
genauen biologischen Abläufe noch immer unklar. Es ist wenig über den
Zusammenhang zwischen der Temperatur und HRV- und Blutparametern
bekannt. Desweiteren wurden die potentiellen Mechanismen des Einflusses
von Schadstoffen und Temperatur auf die Repolarisation bisher kaum un-
tersucht. Studien haben außerdem gezeigt, dass Personen mit genetischen
Prädispositionen oder mit bestimmten Grunderkrankungen, wie Diabetes
mellitus Typ 2, vermutlich empfindlicher auf erhöhte Luftschadstoffkonzen-
trationen reagieren. Um einen besseren Einblick in die biologischen Mecha-
nismen zu erhalten, sind folglich Studien mit Individuen, die möglicherweise
suszeptibel auf Umwelteinflüssen reagieren, notwendig.
In dieser Arbeit habe ich den Effekt der Temperatur auf inflammatorische
und koagulatorische Blutmarker bei Männern mit einer zugrunde liegen-
der Herz- oder Lungenerkrankung untersucht. Ein Absinken der Tempe-
ratur zeigte eine Assoziation mit mehreren Blutmarkern unter anderem mit
der Thrombozytenanzahl, Faktor VII, Fibrinogen und C-reaktivem Protein.
Allerdings unterschieden sich die Richtung und der zeitliche Zusammenhang
der Temperatureffekte zwischen herz- und lungenkranken Probanden. In
einer zweiten Veröffentlichung beobachtete ich bei Herzinfarktüberlebenden
eine Verlängerung des QT-Intervals im Zusammenhang mit erhöhten Fein-
staubwerten. Diese Assoziation war bei Probanden mit mindestens einem sel-
tenen Allel des NFE2L2 Einzelnukleotid-Polymorphismus (SNP) rs2364725
stärker ausgeprägt. Man vermutet, dass das Gen NFE2L2 an der Abwehr
von oxidativem Stress beteiligt ist. Darüberhinaus beobachtete ich eine so-
fortige Erhöhung und eine verzögerte Abflachung der T-Wellen Amplitude in
Assoziation mit erhöhter Schadstoffbelastung. Der Zusammenhang zwischen
Temperatur und T-Wellen Amplitude war invers U-förmig mit den höchsten
Werten bei 5◦C. In einer dritten Studie mit Teilnehmern mit Diabetes oder
gestörter Glukosetoleranz (IGT) fand ich eine verminderte HRV, insbeson-
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dere für die Standardabweichung der NN- (normal to normal) Intervalle, im
Zusammenhang mit einem Anstieg von Feinstaub und ultrafeinen Partikeln.
Diese Effekte waren bei Personen mit IGT stärker ausgeprägt. Die Schad-
stoffeffekte wurden auch durch SNPs mit einem mutmaßlichen Einfluss auf
den Herzrhythmus modifiziert.
Diese Arbeit bestätigt und erweitert die bereits veröffentlichten Studien zu
Kurzzeiteffekten von Schadstoffen auf Parameter der kardiovaskulären Ge-
sundheit. Darüberhinaus ist sie eine der ersten, die Temperatureffekte auf
EKG und Blutmarker untersucht. Bestimmte Vorerkrankungen oder einige
genetische Profile scheinen bestimmte Untergruppen der Bevölkerung em-
pfindlicher gegenüber Umwelteinflüssen zu machen. Die von uns beobachteten
Temperatur- und Schadstoffeffekte auf HRV- und Blutmarker erklären mögli-
cherweise teilweise die bekannten Zusammenhänge zwischen Umweltfaktoren
und kardiovaskulären adversen Ereignissen.
7
3 Introduction
3.1 Cardiovascular health
Cardiovascular disease is the leading cause of global mortality (WHO 2007).
In 2004 worldwide 17.1 million people died from cardiovascular disease re-
flecting 29% of all global deaths. The most common reason for this disease
is the development of atherosclerosis on the inner walls of the blood vessels
which supply the heart or brain. Myocardial infarctions and strokes are acute
events and are mainly caused by a thrombosis preventing blood flow within
the heart or brain. Researchers worldwide explore risk factors for atheroscle-
rosis and thrombosis in order to improve prevention and treatments.
3.1.1 Blood biomarkers and electrogardiogram parameters
Blood biomarkers
Blood markers of inflammation are assumed to be involved in the develop-
ment of atherosclerosis leading to acute as well as chronic cardiovascular
disease. C-reactive protein (CRP), a sensitive marker of the acute-phase re-
sponse, is the most established inflammatory marker for the evaluation and
prediction of cardiovascular health (Libby et al. 2002). CRP as well as inter-
leukin 6 (IL-6), a pro-inflammatory cytokine which activates the release of
CRP, are associated with the development of atherosclerosis. A link between
inflammatory processes has been suggested to be mediated via an oxidative
stress response and an imbalance of the autonomic nervous system (Brook
et al. 2010). Blood markers of coagulation have also been identified as risk
factors of cardiac health (Davi and Patrono 2007); for example platelets can
adhere to the vessel wall and contribute to the development of atheroscle-
rotic lesions, and in case of rupture they trigger the acute onset of arterial
thrombosis. Von Willebrand factor (vWf) is a glycoprotein which mediates
platelet adhesion in response to inflammatory stimuli and endothelial wall in-
jury. Elevated levels of factor VII might indicate an activation of the clotting
cascade. Fibrinogen is a precursor of fibrin which is responsible for thrombus
formation. High levels of fibrinogen are a marker of systemic inflammation,
while moderately elevated levels can indicate systemic activation of the clot-
ting cascade.
Electrocardiogram parameters
Time domain and frequency domain parameters of heart rate variability
(HRV) are putative markers of cardiac autonomic balance (Task Force 1996).
Researchers reported that reduced HRV might be a precursor of cardiovascu-
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lar problems, for instance myocardial infarctions and arrhythmia (Buccelletti
et al. 2009, Lanza et al. 2006). Furthermore, changes in repolarization pa-
rameters such as a prolonged QT-interval and T-wave flattening are further
indicators of adverse cardiac events (Ziegler et al. 2008, Lin et al. 2008).
3.1.2 Air pollution
During the last 20 years, researchers worldwide have reported increased num-
bers of myocardial infarctions (Bhaskaran et al. 2009a, Hsieh et al. 2010),
hospital admissions or emergency room visits (Morris et al. 1995, Tsai et
al. 2009, Zanobetti et al. 2000), and mortality due to cardiac problems
(Dominici et al. 2005, Katsouyanni et al. 2001, Schwartz and Marcus 1990,
Wong et al. 2008) on days with elevated air pollution levels. Especially
particulate matter (PM) with aerodynamic diameters below 10µm (PM10)
and 2.5µm (PM2.5), as well as ultrafine particles (UFP) with a size range of
0.01 to 0.1µm in diameter have been related to the reported adverse health
effects. Although the effects were small, there is strong evidence of a causal
relationship between elevated air pollution levels and cardiovascular health.
Several biological pathways have been suggested which might explain the
observed short-term air pollution effects on cardiovascular health (Brook et
al. 2010, Mills et al. 2009, Pope and Dockery 2006):
• Inhaled particles deposit in the lung and might perturb the balance of
the autonomic nervous system due to a stimulation of lung receptors
or nerve endings in the human airways. This possibly leads to an
activation of the sympathetic nervous system and to a withdrawal of
the vagal tone. Accordingly, it has been shown that PM exposure is
associated with an increase in heart rate (HR), a reduction in HRV,
and changes in repolarization.
• Inhaled particles can induce inflammation, oxidative stress, and the
excess of reactive oxygen species in the lung. On the one hand, inflam-
matory cytokines (e.g. IL-6), acute-phase reactants (e.g. CRP and
fibrinogen), and vascular molecules (e.g. endothelins) are then released
into the circulation possibly leading to a systemic inflammation. On
the other hand, an imbalance of the autonomic nervous system and
hence a decreased HRV might be the consequence.
• It has been shown in both animals and humans that UFP might even
translocate into the circulation. It is assumed that these translocated
particles induce oxidative stress and a local inflammation potentially
destabilizing atherosclerotic plaques. Moreover, UFP could also have
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direct effects on the vascular endothelium, plaques, and clotting possi-
bly leading to an increased risk of ischemia or myocardial infarctions.
These suggested pathways might be activated at differing time points and
they are assumed not to be exclusive but they rather overlap.
Overall, the observed air pollution effects on HRV and markers of inflamma-
tion and coagulation (Chahine et al. 2007, Rückerl et al. 2007, Schneider
et al. 2010) could be precursors of the reported associations between air
pollution and adverse cardiac events.
As it is hypothesized that ambient air pollution acts on the autonomic func-
tion via oxidative stress pathways (Brook et al. 2010) subjects with genetic
predispositions related to these pathways might be especially susceptible.
Accordingly, Chahine et al. (2007) and Schwartz et al. (2005) reported air
pollution effects on HRV in individuals with a reduced defense against oxida-
tive stress due to glutathione S-transferase M1 (GSTM1 ) deletion. Moreover,
Park et al. (2006) observed an air pollution effect modification on HRV by a
SNP in the hemochromatosis (HFE) gene which is supposed to be involved
in iron uptake and oxidative stress.
Furthermore, it is assumed that individuals with diabetes, cardiac or pul-
monary disease are susceptible subpopulations which react stronger to air
pollution exposure than healthy individuals (Brook et al. 2010, Peel et
al.2007, Zanobetti and Schwartz 2001). However, the knowledge of genetic or
disease-related influences and mechanisms on susceptibility to air pollution
is still very limited.
3.1.3 Air temperature
In recent years, the influence of weather conditions, such as air temperature,
on population health has received greater attention. Especially the effects of
heat waves (Kosatsky 2005, Ostro et al. 2009) but also the effects of changes
in moderate temperature on cardiac health have been examined (Bhaskaran
et al. 2009b). Authors have reported an U- or J-shaped association be-
tween air temperature and myocardial infarctions or mortality (Bhaskaran
et al. 2009b, Baccini et al. 2008). That is, cold as well as hot temperatures
increase the number of cardiovascular disease events with lowest effects on
days with a mean temperature between 15◦C and 25◦C depending on the
geographical region. These observed findings might be explained by the fol-
lowing underlying mechanisms:
• Cold temperatures lead to a stimulation of cold receptors in the skin and
to a constriction of skin vessels in order to reduce heat loss. An increase
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in blood pressure and HR might be the consequence (Alperovitch et al.
2009, Keatinge et al. 1984, Näyhä 2005). It has also been suggested
that cold temperatures trigger blood clotting in participants exposed
to cold air or water (De Lorenzo et al. 1999, Keatinge et al. 1984).
Authors reported a seasonal variation of inflammatory markers such
as CRP (Sung 2006) and IL-6 (Kanikowska et al. 2009) with higher
levels during winter compared to spring and autumn. Furthermore, it
has been shown that short-term decreases in air temperature lead to
enhanced levels of CRP, IL-6, and fibrinogen (Schneider et al. 2008).
• In hot weather, the skin vessels enlarge and sweating as well as car-
diac work increases. The risk of thrombosis is enhanced because of an
increased blood viscosity (Keatinge et al. 1986, Näyhä 2005). Further-
more, increases in HR have been observed in participants exposed to
heat under controlled conditions (Keatinge et al. 1986). Kanikowska et
al. (2009) also observed higher levels of IL-6 during summer compared
to spring and autumn.
It has been shown that the elderly, women, and individuals with diabetes are
particularly vulnerable to temperature extremes in association with mortal-
ity (Analitis et al. 2008, Medina-Ramon et al. 2006, Stafoggia et al. 2006).
However, the association between temperature and electrocardiogram (ECG)
parameters as well as blood markers of inflammation and coagulation have
been rarely investigated. It is assumed that climate change might lead to both
increases in average ambient temperature and unexpected drops in temper-
ature due to higher temperature variability. Therefore, further research on
temperature effects on cardiovascular risk markers is necessary.
3.2 Specific aims and results
The main objectives of this thesis were to investigate:
1. The association between air temperature and blood markers of inflam-
mation and coagulation in men with coronary or pulmonary disease.
2. Air pollution and temperature effects on repolarization parameters and
potential air pollution effect modifications by single nucleotide poly-
morphisms (SNPs) involved in detoxification pathways in myocardial
infarction survivors.
3. Modifications of air pollution effects on HR and HRV by SNPs with an
influence on cardiac rhythm among participants with type 2 diabetes
or impaired glucose tolerance.
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For all manuscripts, I developed the specific focus of the research question,
performed the statistical analyses and interpreted the results. I wrote the first
complete draft of the manuscripts and finalized them based on the co-authors
comments. I revised the manuscripts based on the reviewers’ comments af-
ter discussions with my supervisors and wrote the responses to the reviewers.
The analyses of this work are based on three different panel studies conducted
in Erfurt (first publication) and Augsburg (second and third manuscript),
Germany. In each study for each participant clinical examinations were per-
formed repeatedly over a period of several months. Therefore, each partici-
pant acts as his/her own control while the exposures to environmental factors
changed over the time course of the study. Data on health status as well as
disease and smoking history were gathered at a baseline visit and were con-
stant over time. Other time varying potential confounders such as medication
intake was updated at each study visit. For a more detailed description of
the study populations of the first and second study see Rückerl et al. 2006,
Hildebrandt et al. 2009, and Peters et al. 2007. The associations between
air temperature or air pollution and health outcomes were analyzed using
additive mixed models with random participant effects. An appropriate co-
variance structure was chosen in order to account for dependencies between
repeated measurements. All models were adjusted for meteorological vari-
ables and long-term time trend.
In the first publication, I investigated the association between air temper-
ature and blood markers in potentially susceptible non-smoking individuals
with coronary heart disease (CHD, 57 participants with 578 blood with-
drawals) or with a history of doctor-diagnosed impaired lung function and/or
chronic pulmonary disease (38 participants with 381 blood withdrawals). In
contrast to the initial hypothesis, the two panels did not show similar re-
sponses to temperature drops. A 10◦C decrease in the 5-day-average of tem-
perature before the blood withdrawal led to an increase in platelet counts
(%-change from the mean: 3.0%; 95%-confidence interval: [0.6%;5.5%]) and
fibrinogen (5.5% [1.3%; 9.7%]), and to no change in CRP in patients with
pulmonary disease. Opposed to this, the same decrease in the 5-day average
temperature resulted in a decrease in platelet counts (-3.6% [-6.9%;-0.4%]),
fibrinogen (-5.2% [-11.0%;0.7%]), and CRP (-16.1% [-26.8%;-3.8%]) in indi-
viduals with CHD. Diabetic individuals of the CHD panel seemed to be a
susceptible subpopulation as they showed a strong 2-day delayed increase in
factor VII (12.1%[5.8%;18.9%]) associated with temperature drops whereas
no effect was observed for patients with a pulmonary disease (comprising only
two individuals with diabetes) and non-diabetic CHD individuals. The rea-
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son for differing temperature effects in patients with pulmonary or coronary
heart disease might be the complex interplay of blood markers and unknown
underlying mechanisms influencing the response to air temperature. The
panels also differed in disease status and medication. Furthermore, CHD
patients were older and suffered more often from comorbidities than patients
with pulmonary disease. The combination of all these factors possibly af-
fected the susceptibility to temperature changes.
In the second publication, I analyzed air pollution and temperature effects on
repolarization parameters and HR. I also investigated potential air pollution
effect modifications by SNPs supposed to be involved in detoxification path-
ways. Overall, 67 myocardial infarction survivors transmitted 1745 16sec-
ECGs via telephone using a portable ECG device (Philips Viapac). Only
obese participants with a body mass index (BMI)≥ 30kg/m2 or participants
with an intake of beta-adrenergic receptor blockers showed an immediate in-
crease in HR in association with elevated PM2.5 levels. HR did not change in
patients with a BMI<30kg/m2 or without beta-adrenergic receptor blockers.
A one-day lagged prolongation of the Bazett-corrected QT-interval (QTc)
was observed with PM2.5, PM10, and coarse particles in all participants, e.g.
increases in PM2.5 led to a 0.5% [0.0;1.0%] QTc-prolongation. This asso-
ciation was more pronounced in patients with one (0.6%[0.1;1.0%]) or two
(1.2%[0.4;2.1%]) minor alleles of the nuclear factor (erythroid-derived 2)-like
2 (NFE2L2 ) SNP rs2364725, whereas participants with no minor allele did
not react to PM2.5 increases. The NFE2L2 gene is believed to be involved
in the defense against oxidative stress (Goldring et al. 2004). It can only
be speculated that the defense is more activated in patients with common
alleles, whereas patients with at least one minor allele are more susceptible
to PM. In contrast, increases in particle number concentrations (PNC), a
proxy for UFP, led to a 4-day lagged QTc-shortening in participants with at
least one minor allele of rs2364725. Different effects of PM and PNC might
reflect different biological pathways activated by different particle proper-
ties. T-wave amplitude, another marker for the repolarization process, was
positively associated with air pollution levels 0-23h and 24-47h before ECG
transmission and inversely associated with levels more than 48h prior. Fur-
thermore, I found an inverse U-shaped association between temperature and
T-wave amplitude with highest values at 5◦C. Immediate and lagged de-
creases in the T-wave amplitude by 5-9% in association with a temperature
decline of 5◦C on days with average temperatures below 5◦C (cold effects)
and with a 5◦C increase in temperature on days above 5◦C were observed.
Changes in T-wave amplitude and QT-interval can be precursors of sud-
den cardiac death or arrhythmia. In general, the observed air pollution and
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temperature effects on HR and repolarization parameters indicate potential
triggers of adverse cardiac health outcomes.
In the third study I investigated very acute effects on an hourly basis of am-
bient air pollutants on HR and HRV parameters in 61 individuals with type
2 diabetes mellitus or impaired glucose tolerance (IGT). The HRV param-
eters of interest were the standard deviation of normal-to-normal intervals
(SDNN) and the root mean square of successive differences (RMSSD). About
130 SNPs involved in cardiac rhythm which have already been identified in
the literature were used as potential modifiers of the air pollution effects. In
order to reduce the number of performed tests, regression trees for longitu-
dinal data (Sela and Simonoff 2010) were used to single out SNPs with an
influence on repeated measurements of ECG parameters. Only these influ-
ential SNPs were then used as potential effect modifiers. With this method I
was able to select more than 130 SNPs from published genome-wide associa-
tion studies and did not have to restrict the analysis to only a few candidate
SNPs. The analysis of the 207 ECG recordings comprising 1153 1h-intervals
revealed concurrent and lagged decreases in SDNN by about 2-5% in as-
sociation with elevated levels of PM, UFP, black carbon, and sulfate. The
stronges effect modification was for SNP rs333229. Only participants with at
least one minor allele showed a reduction in SDNN. This SNP is located in the
3’untranslated region of the choline transporter gene (CHT1 ) (Neumann et
al. 2005). CHT1 encodes the high-affinity choline transporter (ChT) which
carries choline into acetylcholine (ACh)-synthesizing neurons. ACh is a neu-
rotransmitter of the sympathetic and parasympathetic system. Therefore,
variations in CHT1 may account for variations in ACh neurotransmission
which might lead to a modulation of HR and HRV. However, it can only
be speculated that changes in ChT affect the response to air pollution. An
association between increases in PM10 and PM2.5 and a concurrent reduction
in RMSSD (-5.3%; [-9.3;-1.1%] and -7.2%[-12.2;-1.8%], respectively) was also
observed. Furthermore, RMSSD changed by -3.8%[-7.1;-0.5%] and -5.2%[-
9.8;-0.4%] in association with elevated black carbon levels with a lag of 1h
and 6h, respectively. Elevated air pollution levels led to a concurrent reduc-
tion in RMSSD only in individuals with at least one minor allele of rs2096767,
respectively. In contrast, people with no or one minor allele of rs2745967 ex-
hibited an immediate decrease in RMSSD in association with air pollutants.
I observed no air pollution effects on HR. In general, air pollution effects on
SDNN and RMSSD seemed to be more pronounced in individuals with IGT
than with diabetes. By selecting subjects with IGT, I intended to study the
impact of air pollutants in subjects with an enhanced risk for type 2 diabetes
mellitus but who were not as heavily treated by beta-adrenergic receptor
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blockers, statins, or anti-diabetic medications as individuals with manifest
diabetes. These medications may obliterate the effects of particle exposures.
As in this study 81% of participants with diabetes took beta-blockers, statins,
or anti-diabetic medication it might not have been possible to detect ambient
air pollution effects on ECG-parameters for these individuals.
3.3 Conclusion
This work confirms and extends published results on short-term effects of
environmental stimuli on markers of cardiovascular health. Susceptibility to
environmental conditions seems to depend among others on disease status
and medication intake. Accordingly, I observed differences in the direction
and timing of temperature effects on blood markers of inflammation and co-
agulation between patients with CHD and pulmonary disease. Furthermore,
HR increased in association with elevated air pollution levels only in myocar-
dial infarction survivors without intake of beta-adrenergic receptor blockers.
Moreover, air pollution effects on HRV parameters were only detected in
participants with IGT but not in more heavily medicated individuals with
diabetes. In general, I investigated environmental effects only in participants
with underlying chronic diseases; therefore the results cannot be generalized
to the whole population. However, analyzing particularly susceptible pa-
tients might show stronger reactions to environmental conditions and give
better insights into possible mechanistic pathways. Moreover, as the preva-
lence of diabetes is increasing worldwide, it is important to conduct further
investigations especially in this subpopulation.
Not only disease status but also genetic predispositions might have an influ-
ence on susceptibility to environmental conditions. Genes involved in detox-
ification pathways or with an influence on cardiac rhythm are particularly
interesting. Correspondingly, I found a QTc-prolongation and a reduced HRV
(SDNN) only in participants with at least one minor allele of SNPs involved
in detoxification (NFE2L2 ) or in cardiac rhythm (CHT ), respectively.
Overall, in this thesis I observed changes in HR, HRV, repolarization, and
blood markers of inflammation and coagulation in association with changes
in air temperature and air pollution. These changes may contribute to the
observed associations between environmental conditions and cardiovascular
morbidity and mortality. Although the detected associations between air pol-
lution and ECG and blood markers are only small and might be considered
subclinical, they can give ideas about possible underlying biological path-
ways. Moreover, even small acute changes in blood and ECG parameters
may lead to atherosclerotic progression and chronic effects.
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ABSTRACT
Background and Objective Air temperature changes
are associated with increased cardiovascular and
respiratory risk, but the roles of inflammatory and
coagulation markers are not well understood. We
investigated the associations between temperature and
several blood markers in patients with coronary heart
disease (CHD) and pulmonary disease (PD).
Methods Two studies were conducted in Erfurt,
Germany, over two successive winters. 578 and 381
repeated blood measurements were collected from 57
CHD and 38 PD patients, respectively. Data on patient
characteristics and disease history were gathered at
baseline. Meteorological data were collected from
existing networks. Associations were analysed using
additive mixed models with random patient effects. Effect
modification by diabetes status was investigated only in
CHD patients, as only two PD patients had diabetes.
Results Mean daily air temperature varied between
138C and 168C in both study periods. A 108C decrease
in the 5-day temperature average before blood
withdrawal led to an increase in platelet counts (%
change from the mean: 3.0%, 95% CI 0.6% to 5.5%) and
fibrinogen (5.5%, 1.3% to 9.7%), no change in C-reactive
protein in PD patients, and a decrease in C-reactive
protein in CHD patients. A 2-day delayed increase in
factor VII associated with temperature decrease was
seen in CHD patients (4.9%; 0.7% to 9.2%), while PD
patients showed no effect. ‘Effects in CHD patients
without diabetes’ into ‘Effects on factor VII in CHD
patients without diabetes’.
Conclusions This study suggests that temperature
decrease is associated with change in several blood
parameters. The complex interplay of blood markers at
low temperature may contribute to the observed
association between cold and cardiovascular mortality
and morbidity.
INTRODUCTION
Several studies have shown that changes in air
temperature are associated with hospital admis-
sions1 2 and mortality3e5 due to cardiovascular
events. Elderly people and those with diabetes or
chronic obstructive pulmonary disease (COPD)
seem to be susceptible to extreme weather
conditions.6e8However, theunderlyingmechanisms
of the relationship between temperature and
cardiovascular morbidity remain poorly understood.
Earlier studies on the controlled exposure of
participants to cold air or water revealed an increase
in the levels of red blood cells (RBC), platelets,
factor VII (FVII) and fibrinogen and a decline in von
Willebrand factor (vWf).9e11 A Taiwanese study12
found higher mean fibrinogen and FVII concentra-
tions on days with an ambient temperature equal
to or below 208C compared to days with an
ambient temperature above 208C. Seasonal varia-
tions in C-reactive protein (CRP) levels were
observed in healthy Koreans with higher values
during winter and spring than in summer.13 The
association between temperature and repeated
fibrinogen, CRP and interleukin-6 (IL-6) measure-
ments was assessed in a multi-centre European
study of survivors of myocardial infarction.14 A
decrease in temperature 3 days before the measure-
ment was associated with an increase in fibrin-
ogen, CRP and IL-6 levels seemed to be related to
average temperature changes in the previous 5
days.
It is hypothesised that a wide range of blood
markers are involved in the development of
atherosclerosis leading to chronic as well as acute
cardiovascular disease. In patients with coronary
or pulmonary disease, increased levels of inflam-
matory or coagulation markers might predict
future cardiovascular events.15 16 Therefore,
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elevated blood markers due to decreased temperature might
indicate cardiovascular health. The objective of our study was to
assess the influence of temperature on repeated measurements of
cellular blood components, adhesion molecules and coagulation
as well as inflammatory markers as indicators for cardiovascular
health in susceptible subgroups. We investigated the direction
and temporal delay of the temperatureeblood marker response
and whether this differs in subjects with pulmonary and
cardiovascular disease. Our hypothesis was that there would be
a similar response to temperature stimuli in both groups.
Abnormalities in the haemostatic system and low-grade
systemic inflammation were found in people with diabetes.17 18
Nakaji et al19 observed an increase in diabetes-related mortality
during the winter season in Japan; thus, we were also interested
in the possible effect modifications of diabetes status on the
relationship between temperature and blood markers.
METHODS
Study populations
As part of the University of Rochester Particulate Matter Center
investigations, two prospective panel studies were conducted in
Erfurt, Germany. The first study was carried out between 15
October 2000 and 27 April 2001 with a group consisting of
non-smoking men with coronary heart disease (CHD). Male
participants with a history of doctor-diagnosed impaired lung
function and/or chronic pulmonary disease took part in the
second study between 15 October 2001 and 6 May 2002.
All participants signed a written consent form and the study
protocol was approved by the Ethics Commission of the Bavarian
Chamber of Physicians (‘Bayerische Landesaerztekammer ’).
Patients taking anti-coagulants (except for acetylsalicylic acid)
and those with an implanted cardiac pacemaker, a recent (<3
months previously) myocardial infarction, bypass surgery,
coronary angioplasty or diabetes mellitus type I were excluded
from both groups. Additionally, participants in the pulmonary
disease (PD) group with pneumoconiosis (silicosis or asbes-
tosis), more than three hospitalisations for COPD in the
previous year, or continuing oxygen therapy and those who
had taken antibiotics more than four times during preceding
6 months or winter half-year were excluded.
Clinical measurements
For each participant up to 12 clinical examinations were
scheduled every two weeks on the same week day and at the
same time of day. At the first visit, a baseline questionnaire was
administered regarding health status, pulmonary and cardiac
symptoms, medication and smoking history. Each visit included
a short interview and ethylenediaminetetraacetic acid (EDTA)
and citrate plasma samples were drawn (Becton Dickinson,
Franklin Lakes, NJ). Samples were centrifuged and aliquots were
immediately stored at 208C until analysis. All blood specimens
were analysed using an Abbott Cell-Dyn 1800 cell counter
(Abbott, Wiesbaden, Germany). Intercellular adhesion molecule
1 (ICAM-1), endothelial-leukocyte adhesion molecule (E-
selectin) (R&D Systems, Wiesbaden, Germany), prothrombin
fragment 1+2 (Dade Behring, Marburg, Germany) and soluble
CD40 ligand (sCD40L) were measured by means of a commer-
cial enzyme-linked immunosorbent assay (ELISA). sCD40L
measurements were only available for the CHD group. D-dimer
and vWf were analysed using an immunoturbidimetric method
and FVII by clotting time (Diagnostica Stago, Asnieres-sur-Seine,
France). Fibrinogen, CRP (high-sensitivity assay) and serum
amyloid A (SAA) were analysed by immunonephelometry (Dade
Behring).
Meteorological data
Hourly data on temperature, relative humidity and barometric
pressure were collected from existing networks. For each person
and visit, the individual 24 h average of each meteorological
variable preceding the visit (0e23 h before blood withdrawal) for
up to 4 days (24e47 h, 48e71 h, 72e95 h, 96e119 h) before the
examination were calculated if more than two thirds of the
hourly measurements were available for this period. Addition-
ally, we calculated the mean of these 5 days (5-day average).
Statistical analysis
Analyses were performed with SAS (v 9.1) in both groups
separately. The medians of patient-specific correlation coeffi-
cients between all blood markers were calculated. In order to
compare the blood parameters between the groups, the two
datasets were combined and mixed models with random patient
effects were conducted including a dummy variable for the
group effect. We assumed a compound symmetry structure for
the covariance matrix, as the half-lives of the markers were
much shorter than the intervals between the visits. To compare
the meteorological variables between the groups, a regression
model with a first-order autoregressive covariance structure was
used to account for the dependencies between the repeated
measurements. The p value of the group effect indicates
whether the blood markers and meteorological variables differ
significantly between the groups. The patient characteristics of
both groups were compared using a t test for metric variables
and a c2 test for categorical variables. In case of less than five
observations in one category, Fisher ’s exact test was used.
Regarding the estimation of temperature effects, the data of
each group were analysed separately using additive mixed
models with random patient effects and a compound symmetry
covariance structure. In both groups, prothrombin fragment 1
+2, CRP, SAA and D-dimer and, only in the CHD group,
sCD40L and FVII were log-transformed in order to produce
normally distributed residuals. Penalised splines (P-splines) were
used to allow for non-linear exposureeresponse functions and
for non-linear confounder adjustment (S Greven, H Küchenhoff,
A Peters, personal communication, 2008).
Confounder models were built separately for each blood
parameter. Model selection was carried out by minimising
Akaike’s information criterion. Continuous confounders were
included linearly or smoothly as P-splines depending on the
Akaike’s information criterion value. Long-term time trend and
relative humidity with the same lag as the temperature term
were forced into the model. Barometric pressure with the same
lag as the analysed temperature lag and day of the week were
only included in case of model fit improvement. Two variables
with questionnaire information indicating an airway infection
or antibiotic intake 2 weeks before blood withdrawal were
forced into the model to account for possible inflammation
unrelated to a change in temperature. In addition, for the PD
group, a variable for corticosteroid intake was also taken into
account. Observations with obviously large residuals in the
confounder model were excluded.
After completion of the confounder models, the effects of
temperature lags were estimated linearly as well as smoothly as
P-splines. The linearly estimated temperature effects are
presented as per cent change in the outcome mean per 108C
decrease in temperature together with 95% CIs. We chose to
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present the effects of a decrease in temperature because both
groups were mainly studied in the winter.
Effect modification
We considered body mass index (BMI) (#30 kg/m2 vs >30 kg/
m2), hypertension (yes vs no), age (#60 years vs >60 years) and
statins (intake vs no intake) as potential effect modifiers. The
interaction with diabetes type II (yes vs no) was only analysed
for the CHD group as only two patients in the PD group had
diabetes. Additionally, interactions with smoking status (current
smokers vs non-smokers) and b2-agonists (intake vs no intake)
were analysed for PD patients.
Sensitivity analyses
To check the robustness of our models we performed several
sensitivity analyses. Temperature effects were calculated
including observations with extremes in the residuals to avoid
exclusion of observations possibly sensitive to temperature
changes and to test the sensitivity of the results to our main
model. Also, patients with pulmonary disease (COPD, chronic
bronchitis) were excluded from the CHD group, and patients
with coronary disease (CHD, angina pectoris and previous
myocardial infarction) from the PD group. Additionally, we
separately added particulate matter with a diameter below
10 mm (PM10) or ultrafine particles (UFP) with the same lag as
temperature, as well as with the most influential lag, to the
original confounder model. Polynomial distributed lag (PDL)
models were calculated, which include all temperature lags
simultaneously. In order to avoid multicollinearity, we used an
Almon distributed lag model,20 which forces estimates to
a polynomial shape. The sum of the lagged temperature effects
resulting from a PDL model were compared with the effect of
the 5-day temperature average.
RESULTS
Study populations
Of the initial 61 CHD patients, one refused to participate, two
were excluded due to disease causing changes in blood markers
(leukaemia, lymphoma) and one was excluded because of
constantly elevated levels of leukocytes and erythrocytes, indi-
cating an unknown underlying disease. The CHD group there-
fore comprised 57 men. Fifty five patients participated in 12
scheduled visits, while two attended nine and eight examina-
tions, respectively. If patients reported an acute infection and/or
surgery during the 2 weeks before the examination or if nurses
saw signs of acute infection, the blood samples of the respective
visits were excluded (46 blood samples from 19 patients). As not
all patients were able to give the scheduled amount of blood at
each visit, 578 (85%) blood samples remained for analysis.
The data of 38 of 42 male PD participants were used for
analyses: three participants with a single measurement and one
patient with a cancer diagnosis were excluded. In total, 438
(96%) of the targeted 456 visits were carried out. Blood with-
drawal failed for technical reasons on 10 occasions and 47 blood
samples were excluded because of fever the week before with-
drawal or a diagnosed airway infection on the day of the visit.
Thus, 381 (87% of 438 blood withdrawals) valid blood samples
were available for analysis. The majority of patients had chronic
bronchitis and/or asthma with normal pulmonary function tests
measured as forced expiratory volume in 1 s (FEV1)/forced vital
capacity ratios above 70%. Two patients had mild, seven
moderate (50%£FEV1/FEV1predicted <80%) and five severe (30%£
FEV1/FEV1predicted <50%) COPD.
The PD and CHD groups are described in table 1. CHD
patients were significantly older than PD patients: the age of
CHD and PD patients ranged from 51 to 76 years and from 35
and 78 years, respectively. Significantly more patients with
chronic bronchitis were observed among CHD patients with
diabetes than without diabetes. Overall, the PD group was
healthier as the participants tended to be less obese and it
included only two patients with diabetes, while the CHD group
included 13 patients with diabetes.
Clinical measurements
Levels of blood parameters are summarised in table 2. Except for
E-selectin, vWf, D-dimer and SAA, PD patients tended to have
higher values than CHD patients. Only platelets, prothrombin
fragment 1+2 and ICAM-1 showed significant differences
between the groups. CHD patients with diabetes had higher E-
selectin and ICAM-1 levels compared to CHD patients without
diabetes. CRP and SAA showed a moderate correlation of r¼0.7
(CHD) and r¼0.6 (PD) in both groups. None of the remaining
blood markers were strongly correlated (|r|<0.4) in either
group.
Meteorological data
Meteorological data were measured on 198 and 204 days for the
CHDand PDgroups, respectively (see online supplemental table 1).
The mean temperature during both study periods was 48C (SD
58C). Mean relative humidity was 84% (SD 9%) and 83% (SD
12%) and mean barometric pressure was 973 hPa (SD 10 hPa)
and 980 hPa (SD 11 hPa) for the CHD and PD groups, respec-
tively. Only barometric pressure showed a significant difference
between the groups. The meteorological variables exhibited only
low correlation (|r|#0.3). Online figure 1 compares the time
series of temperature in both groups.
Effects of air temperature
There was no evidence in either group for a deviation in the
linearity of the relationship between temperature and blood
markers (data not shown). Figures 1 and 2 show the immediate,
lagged and cumulative effects of a 108C decrease in temperature.
All figures are presented with the same scaling except for RBC
which exhibits very small temperature effects. The association
between temperature and RBC was quite similar for both
groups, but with an immediate significant effect in CHD
patients (0.7%, 0.0% to 1.4%). In contrast, CHD patients reacted
to a drop in temperature, particularly the 5-day average, with
decreased (3.6%, 6.9 to 0.4%) platelet levels, whereas PD
patients responded with increased (3.0%, 0.6% to 5.5%) platelet
levels. A decline in temperature was associated with an increase
in sCD40L in CHD patients, with the 5-day temperature average
showing the largest effect (18.5%, 5.1% to 33.5%). Only in PD
patients was a decline in all temperature lags associated with
increased E-selectin levels. A drop in temperature for the 5-day
average led to a 4.6% (0.2% to 9.1%) increase in ICAM-1 in CHD
patients. A 6.5% (12.7% to 0.2%) reduction in vWf
24e47 h before blood withdrawal was detected in PD patients.
We observed large differences between the groups for the rela-
tionship between temperature and FVII. While PD patients
showed an immediate decrease in FVII (5.6%, 10.4 to
0.7%), CHD patients exhibited an inverse association of
roughly the same size with a delay of 2 days (4.9%, 0.7% to
9.2%). We found only in PD patients an association between
temperature and prothrombin fragment 1+2 with a delay of
1e3 days with the largest effect for the 5-day average (25.9%,
7.6% to 47.3%). No clear effects were detected for fibrinogen. A
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decrease in temperature 96e119 h before blood withdrawal and
in the 5-day average led to a borderline significant reduction of
about 5% in CHD patients, whereas PD patients showed
elevated fibrinogen levels for a temperature decrease 24e47 h
(5.0%, 1.2% to 8.7%), 48e71 h (5.2%, 2.0% to 8.4%) and
72e95 h (3.4%, 0.5% to 6.4%) before blood withdrawal and for
the 5-day temperature average (5.5%, 1.3% to 9.7%). We
detected only in CHD patients influential associations between
a temperature decrease and CRP. Nearly all temperature lags
showed a statistically significant or borderline decrease in CRP,
with the largest influence for the 5-day temperature average
(16.1%, 26.8% to 3.8%). In both groups we found no
influence of temperature on WBC, D-dimer or SAA (data not
shown).
Effect modification
Only CHD patients with diabetes exhibited a decrease in
platelets in association with a decline in temperature (figure 3).
Participants with and without diabetes showed elevated and
decreased levels of E-selectin and vWf, respectively, due to
a decrease in temperature, which were not significant. We
observed the largest interaction effects between temperature and
diabetes on FVII. Patients with diabetes showed strongly
elevated FVII values for a decrease in temperature for almost all
lags, while there were no effects for patients without diabetes.
No significant interactions by diabetes were detected in associ-
ation with the remaining blood markers.
Temperature effects on platelets were more pronounced in
CHD patients without statin intake, whereas CHD patients
taking statins showed larger effects on E-selectin (data not
shown). In PD patients we observed only temperature effects
on prothrombin fragment 1+2 in patients with statin intake.
Throughout all 24 h lags, these participants exhibited signifi-
cantly elevated levels due to a drop in temperature, whereas the
effect of patients who did not take statins was smaller and
mostly not significant. In both groups, no significant interac-
tions of temperature with age, BMI or hypertension were
detected. Smoking status and intake of b2-agonists did not
modify the temperatureeblood marker response in PD
patients.
Sensitivity analyses
In both groups the temperature effects remained robust after
adjustment for air pollution. Only in CHD patients were
temperature effects on RBC, ICAM-1 and vWf more pronounced
after adjusting for PM10 with the same lag as temperature. The
exclusion of PD patients from the CHD group and of patients
with coronary disease from the PD group did not change our
Table 1 Baseline characteristics of the PD and CHD groups
CHD group (n[57) PD group (n[38)
All mean (SD)
or n(%)
No diabetes
mean (SD) or n(%) Diabetes, N (%)
p Value (no diabetes
vs diabetes) mean (SD) or n(%)
p Value
(PD vs CHD)
Age (years), mean (SD) 66.3 (6.0) 66.0 (6.2) 67.3 (5.7) 0.50* 53.8 (12.3) <0.001*
BMIz (kg/m2), mean (SD) 28.1 (3.4) 28.2 (3.4) 27.6 (3.5) 0.57* 25.5 (3.7) 0.06*
Age (years)
#60 8 (14) 7 (16) 1 (8) 0.67z 17 (45) <0.001y
>60 49 (86) 37 (84) 12 (92) 21 (55)
BMI (kg/m2)
#30 42 (74) 31 (70) 11 (85) 0.48z 33 (87) 0.12y
>30 15 (26) 13 (30) 2 (15) 5 (13)
Smoking
Never smoker 15 (26) 14 (32) 1 (8) 0.15z 8 (21) 0.003z
Ex-smoker 42 (74) 30 (68) 12 (92) 23 (61)
Current smoker 0 (0) 0 (0) 0 (0) 7 (18)
History of
Coronary heart disease 57 (100) 44 (100) 13 (100) e 11 (29) <0.001z
Angina pectoris 39 (68) 29 (67) 10 (77) 0.73z 15 (40) 0.004y
Myocardial infarction 43 (57) 33 (75) 10 (77) 0.89y 8 (21) <0.001y
Bypass surgery/balloon
dilatation
49 (68) 37 (84) 12 (92) 0.67z 4 (11) <0.001z
COPDx (mild to severe) 5 (9) 5 (11) 0 (0) 0.58z 14 (37) <0.001y
Chronic bronchitis 2 (4) 0 (0) 2 (15) 0.05z 29 (76) <0.001z
Emphysema 0 (0) 0 (0) 0 (0) e 5 (13) 0.009yy
Bronchial asthma 0 (0) 0 (0) 0 (0) e 20 (53) <0.001yy
Hypertension 40 (70) 32 (73) 8 (62) 0.44y 14 (37) 0.001y
Diabetes 13 (23) 0 (0) 13 (100) e 2 (5) 0.02z
Medication use
Acetylsalicylic acid 53 (93) 42 (96) 11 (85) 0.22z 11 (29) <0.001z
Statins 28 (49) 22 (50) 6 (46) 0.81y 7 (18) 0.002y
b2-Agonists 4 (7) 3 (7) 1 (8) 1.00y 21 (56) <0.001z
Theophylline 6 (11) 5 (11) 1 (8) 1.00y 17 (45) <0.001y
Glucocorticosteroids 4 (7) 3 (7) 1 (8) 1.00y 18 (47) <0.001z
*t test;
yc2 test;
zFisher’s exact test.
BMI, body mass index; CHD, coronary heart disease; COPD, chronic obstructive pulmonary disease; PD, pulmonary disease.
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findings. The sums of the lagged temperature effects resulting
from PDL analyses were comparable to the effects of 5-day
temperature average on all blood markers in both groups (data
not shown).
DISCUSSION
Summary
We investigated the cardiovascular effects of temperature in two
susceptible subgroups. We observed opposite air temperature
effects between the groups for platelets, E-selectin, prothrombin
fragment 1+2, FVII and fibrinogen. In association with a 108C
decline in temperature, PD patients showed an increase in blood
parameters except for FVII, while CHD patients showed
constant or decreased blood marker levels. Inverse immediate
and lagged effects were found on sCD40L, which was measured
in the CHD group only. Immediate decreased FVII levels in
association with a 108C decrease in the 24 h temperature average
were detected in PD participants, whereas CHD patients
showed increased FVII levels with a delay of 48e71 h. Patients
with CHD and diabetes showed in particular a strong associa-
tion between temperature and platelets as well as FVII, whereas
no or opposite effects were observed in both PD and CHD
participants without diabetes, respectively. The results indicate
that decreases in temperature might lead to changes in coagu-
lation markers and adhesion molecules, suggesting a biological
mechanism for the observed temperature-related variation in
cardiovascular event frequency.
Air temperature and blood parameters
RBC tended to increase as temperature decreased. These findings
support other studies which showed elevated RBC after
cooling.9 11 Elwood et al21 found an absolute increase in platelets
of 163103/ml in association with a 168C decrease in temperature
which is comparable with the 103103/ml platelet increase in PD
patients for the same temperature decline found in our analysis.
Increased platelet counts were also observed during mild surface
cooling,11 probably as a consequence of cold-induced sympa-
thetic activity. Contrary to our findings in PD participants, we
observed a positive association in CHD patients. Considering
the significantly increased sCD40L levels in CHD participants,
the decrease in platelets could be the consequence of platelet
aggregation due to activation of platelets.22 Unfortunately, no
sCD40L data were available for the PD group to allow us further
investigate this hypothesis. De Lorenzo et al10 showed that vWf,
a glycoprotein which mediates platelet adhesion, decreased in
healthy participants due to cold adaptation following whole
body water immersion. In our results, reduced vWf levels in
association with a drop in temperature were seen in both
groups. However, the effects were mostly not significant.
FVII activates the clotting cascade and Woodhouse et al23
observed enhanced FVII clotting activity values in the elderly
during winter. However, one should only cautiously refer to
studies comparing winter-time and summer-time levels of blood
markers, as the differences may be due to differences in influenza
occurrence rather than temperature changes. Yeh et al12 found
higher mean FVII levels in Taiwanese subjects on days with
a temperature equal to or below 208C in comparison to days
exceeding 208C. Although temperature ranges between our and
the Taiwanese study differed, we also detected cold effects on
FVII in CHD patients. Opposite effects were observed in PD
participants. Several studies21 23 24 observed enhanced fibrinogen
levels in the elderly during winter. To our knowledge there was
only one study which assessed the influence of temperature on
repeated measurements of fibrinogen. Schneider et al14 observed
increased fibrinogen levels in association with a decrease in
temperature in survivors of myocardial infarction. A 108C drop
in temperature 72e95 h before blood withdrawal led to a 1.32%
(0.2% to 2.4%) increase in fibrinogen. We also found lagged
temperature effects in PD patients, but our effects were larger
and significant for several lags. However, in CHD patients
a delayed decrease in fibrinogen was found. This is in accordance
with the report by Frohlich et al25 who reported peak fibrinogen
levels in April and lower levels in winter. Fibrinogen is
a precursor of fibrin which is responsible for thrombus forma-
tion. High levels of fibrinogen are a marker of systemic inflam-
mation, while low levels can indicate systemic activation of the
clotting cascade. Schneider et al14 detected elevated values of
CRP in relation to a decline in temperature. However, we found
no effect on CRP in PD patients and a decrease in CRP for
almost all lags in CHD patients. The findings on seasonal
changes of CRP are controversial. While Sung13 reported
seasonal variation in CRP levels with a peak in winter,
Table 2 Blood marker levels for PD and CHD patients
CHD group (N[57) PD group (N[38)
All No diabetes Diabetes p Value*
(no diabetes
vs diabetes)n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD)
p Value (PD
vs CHD)
WBC (31000/ml) 576 6.7 (1.6) 447 6.6 (1.6) 129 7.2 (1.6) 0.15 379 7.0 (1.9) 0.36
RBC (31000/ml) 575 4.6 (0.4) 447 4.6 (0.3) 128 4.5 (0.4) 0.33 379 4.6 (0.3) 0.66
Platelets (31000/ml) 572 184.4 (64.1) 445 180.0 (43.4) 127 199.8 (108.0) 0.39 380 255.9 (62.9) <0.001
sCD40L (pg/ml) 538 5256 (4480) 423 5327 (4751) 115 4993 (3299) 0.79 e e (e) e
E-selectin (ng/ml) 571 54.1 (26.3) 446 49.4 (19.8) 125 70.7 (37.5) 0.03 376 50.0 (20.7) 0.60
ICAM-1 (ng/ml) 572 271.2 (72.1) 446 259.1 (58.1) 126 314.2 (96.7) 0.01 377 300.7 (97.6) 0.02
vWF (% activity) 544 134.3 (57.3) 423 131.4 (53.4) 121 144.6 (68.5) 0.28 349 126.4 (43.4) 0.41
FVII (% activity) 535 120.7 (33.0) 418 119.7 (33.3) 117 124.1 (31.6) 0.78 345 130.2 (32.8) 0.06
Prothrombin
fragment 1+2
(nmol/l)
541 1.5 (1.8) 423 1.5 (1.6) 118 1.7 (2.5) 0.18 345 2.2 (1.0) <0.001
Fibrinogen (g/l) 573 2.9 (0.7) 444 2.9 (0.7) 129 2.9 (0.7) 0.98 374 3.0 (0.7) 0.41
D-dimer (mg/ml) 546 0.7 (1.1) 425 0.6 (0.5) 121 1.1 (2.1) 0.22 347 0.4 (0.6) 0.14
CRP (mg/l) 575 3.4 (4.1) 446 3.1 (3.3) 129 4.6 (5.8) 0.08 379 3.5 (5.5) 0.77
SAA (mg/l) 575 5.1 (8.7) 446 4.8 (8.9) 129 6.0 (7.9) 0.23 378 4.6 (8.4) 0.64
*p Value of fixed group effect in mixed effects model.
CHD, coronary heart disease; CRP, C-reactive protein; E-selectin, endothelial-leukocyte adhesion molecule; FVII, factor VII; ICAM-1, intercellular adhesion molecule 1; PD, pulmonary disease;
RBC, red blood cell count; SAA, serum amyloid A; sCD40L, soluble CD40 ligand; vWF, von Willebrand-factor antigen; WBC, white blood cell count.
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Horan et al26 and Frohlich et al27 found no seasonal variation.
CRP is the most established inflammatory marker used to
evaluate and predict cardiovascular health.15 However, we
mainly observed changes in coagulation markers which might
also be relevant in the development of acute coronary syndromes
and in thrombus formation.28
Air temperature and blood parameters in patients with diabetes
We detected interaction effects between diabetic status and
temperature on platelets, E-selectin, vWf and FVII in CHD
patients. The inverse influence of a drop in temperature on FVII in
all CHD patients might be based on the strong inverse tempera-
ture effect in people with diabetes. CHD patients without dia-
betes showed non-significant effects comparable to the estimates
for the PD group,which included only two patientswith diabetes.
While smaller or opposite effects were detected in patients
without diabetes, a decline in temperature also led to decreased
platelets and slightly increased E-selectin and vWf levels in
patients with diabetes. The haemostatic system in individuals
with diabetes exhibits various abnormalities17 such as endothelial
Figure 1 Per cent change per 108C decrease in temperature in mean levels of red blood cells (RBC), platelets, soluble CD40 ligand (sCD40L),
E-selectin, intercellular adhesion molecule 1 (ICAM-1) and von Willebrand-factor antigen (vWF). CHD, coronary heart disease; PD, pulmonary disease.
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damage and elevated coagulation markers. The decrease in plate-
lets in association with a temperature drop might be due to
enhanced vWf levels which promote platelet adhesion to the
damaged endothelial tissue and subsequent platelet activation.29
Our analyses revealed that patients with diabetes seem to be
a susceptible subpopulation which reacted more strongly to cold
temperature. This finding needs further investigation as
Schwartz6 and Medina-Ramon and Schwartz30 observed in case-
only analyses increased hospital admissions and deaths in patients
with diabetes on extremely hot days but no effects of extreme
cold. As the study periods of our groups were limited to the cold
season we expected no heat effects.
In summary, contrary to our initial hypothesis, the relationship
between temperature and most blood markers differed between
the groups or clear temperature effects were detected only in one
group. CHD patients in our study were older and more often had
hypertension and diabetes than PD patients. Medication also
varied because of different disease patterns between the groups.
The combination of all these factors possibly affected blood
markers and susceptibility to temperature. Thus, differences in
the effect of temperature between the groups could not be fully
explained by a single patient characteristic. It is possible that
underlying, but currently unknown, mechanisms influencing the
association between temperature and blood markers might differ
between the two susceptible subgroups. However, it is also
possible that our results are only due to chance.
Air temperature and cardiovascular events
As several studies5 31 observed increases in cardiovascular events
due to a decline in temperature, our analyses might identify
intermediate steps linking temperature changes to cardiovas-
cular health. The influence of temperature on cardiovascular
eventshas alsobeendescribedbyU-,V- or J-shaped functions.2 32e34
In this context, it is important to note that the clinical examina-
tions of the CHDand PDpatients took place fromOctober toApril
or May, respectively. The maximum 24 h averages in temperature
during both studyperiods never exceeded 168C.Weassume that our
results reflect the left part of a U- or V-shaped temperatureeblood
marker response as it has been shown that cardiovascularmortality
is lowest on days with a mean temperature between 158C and
208C.34
Strengths and limitations
We were able to analyse intra-individual variation as patients
with PD or CHD participated in up to 12 consecutive blood
measurements. Further strengths are the non-linear confounder
adjustment and the information on patient characteristics
allowing us to perform subgroup analyses. However, the find-
ings are limited in that the measured blood markers are easily
influenced by infections. CRP is particularly sensitive to infec-
tious disease and can increase a thousand-fold within a short
time.35 We therefore excluded the blood samples of participants
with an acute infection during their visit and we additionally
Figure 2 Per cent change per 108C decrease in temperature in mean levels of factor VII (FVII), prothrombin fragment 1+2, fibrinogen and C-reactive
protein (CRP). CHD, coronary heart disease; PD, pulmonary disease.
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adjusted for intake of antibiotics and airway infections during
the 2 weeks prior to the examination. It can therefore be
assumed that the presented effects result from a temperature
decrease and not from an infectious disease. It has also been
shown that air pollutants might be associated with blood
markers.36e42 It is still unclear whether air pollutants confound
or modify the temperatureeblood marker response. However,
adjustment for air pollution hardly changed our results.
There is no standard technique to determine sCD40L and it
has been shown that sCD40L levels may be influenced by the
method employed. However, in our study all samples were
analysed at the same time and under the same conditions (for
further details, see Rückerl et al22). Moreover, the change in the
sCD40L level within one patient was used for analysis, rather
than the absolute level, and therefore the assay itself cannot
have influenced the results.
One limitation is that we investigated the influence of
temperature on blood parameters in men with severe disease on
different medication. Hence, they are a highly selected group
which might show differing reactions to temperature changes
compared to women or healthy subjects, leading to reduced
generalisability of our results. On the other hand, analysing
vulnerable groups might provide more mechanistic insights and
provide ideas for instituting new precautions. A further limita-
tion is that only outdoor temperature was measured although
people usually spend a lot of time indoors, especially in winter.
However, as numerous studies have shown that the risk for
cardiovascular events increases during the cold season,5 34 we
assume that short exposure to outdoor temperature can also
influence blood markers.
CONCLUSION
The present study suggests that a decrease in temperature is
associated with changes in several blood parameters. The
direction and timing of the relationship differed between CHD
and PD patients. The complex interplay of blood markers at low
temperature may contribute to the observed association
between cold and cardiovascular mortality and morbidity.
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30 4 AIR TEMPERATURE AND BLOOD MARKERS
Supplemental Material, Table 1. Description of meteorological variables in
the CHD and PD panel.
Panel N Mean SD Min 25% Median 75% Max IQR
Air temperature CHD 198 4.1 4.8 -10.5 0.7 4.4 7.8 13.2 7.1
(◦C) PD 204 4.1 5.4 -12.8 0.2 4.7 8.4 15.7 8.1
Barom. pressure CHD 198 973.2 9.8 949.8 966.2 972.9 979.9 995.6 13.7
(hPa) PD 204 979.7 10.6 952.8 972.6 979.7 987.1 1002.3 14.5
Rel. humidity CHD 198 83.5 8.9 56.5 78.5 84.5 89.1 100 10.6
(%) PD 204 82 11.7 48.8 75 84.3 90.6 100 15.6
CHD: Coronary heart disease, PD: Pulmonary disease, SD: Standard deviation, IQR: Interquartile range
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Research
Numerous studies have shown that elevated 
ambient air pollutants and changes in air 
temperature are associated with increases in 
hospital admissions and mortality due to car-
diovascular events (Analitis et al. 2008; Pope 
and Dockery 2006). The effects of air pollu-
tion on heart rate (HR) and heart rate variabil-
ity (HRV) have been studied more extensively 
since the initial publications by Pope et al. 
(1999), Peters et al. (1999), and Gold et al. 
(2000). For example, researchers reported a 
reduced HRV in susceptible participants such 
as senior adults (Luttmann-Gibson et al. 2006) 
and patients with coronary artery disease 
(CAD) (Timonen et al. 2006). Increased levels 
of air pollution have been shown to enhance 
the risk for ST-segment depression (Pekkanen 
et al. 2002) and arrhythmia (Berger et al. 
2006). It is hypothesized that the observed 
associations between HR and HRV and air 
pollutants are a consequence of the activation 
of the autonomic nervous system or a direct 
affection of the electric system of the heart 
(Pope and Dockery 2006). Little is known 
about the influence of temperature on HR 
and HRV. Drops in temperature may acti-
vate the sympathetic nervous system via stim-
ulation of cold receptors in the skin, which 
may result in increased catecholamine levels. 
The consequences are vasoconstriction and 
increased blood pressure (Alpérovitch et al. 
2009; Pääkkönen and Leppaluoto 2002).
Potential mechanisms of the influence 
of air pollutants and temperature on repo-
larization have received less attention. Some 
researchers have hypothesized that a prolonged 
QT interval and T-wave abnormalities might 
trigger the onset of arrhythmias (Roden 2008) 
and increase the risk for coronary deaths 
(Greenland et al. 2003). Only a few studies 
have investigated the relationship between ele-
vated levels of particulate matter (PM) air pol-
lution and repolarization thus far (Ghelfi et al. 
2008; Henneberger et al. 2005; Zareba et al. 
2009), and little is known about the tempera-
ture influence on these parameters.
The main objective of our study was to 
evaluate the influence of air pollutants and 
air temperature on repeated measurements 
of HR and repolarization parameters, such as 
Bazett-corrected QT interval (QTc) (Bednar 
et al. 2001) and T-wave amplitude (Tamp).
Because specific single-nucleotide poly-
morphisms (SNPs) have been reported to 
modulate the QT interval (Pfeufer et al. 
2009), we examined modifications of the 
association between air pollution and elec-
trocardiogram (ECG) parameters by SNPs 
involved in detoxification pathways.
Materials and Methods
Study population. A panel study of non-
smoking myocardial infarction (MI) survi-
vors was conducted in Augsburg, Germany, 
between 30 May 2003 and 1 February 
2004, as a substudy of the AIRGENE (Air 
Pollution and Inflammatory Response 
in Myocardial Infarction Survivors: Gene-
Environment Interaction in a High Risk 
Group) study. Only persons who had sur-
vived an MI between 3 months and 6 years 
before entry into the study were included. 
All methods used in the study center were 
conducted according to common standard 
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All participants gave written informed con-
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Altered Cardiac Repolarization in Association with Air Pollution 
and Air Temperature among Myocardial Infarction Survivors
Regina Hampel,1 Alexandra Schneider,1 Irene Brüske,1 Wojciech Zareba,2 Josef Cyrys,1,3 Regina Rückerl,1 
Susanne Breitner,1 Harald Korb,4 Jordi Sunyer,5 H.-Erich Wichmann,1,6 and Annette Peters1
1Helmholtz Zentrum München—German Research Center for Environmental Health, Institute of Epidemiology II, Neuherberg, 
Germany; 2Cardiology Division, University of Rochester Medical Center, Rochester, New York, USA; 3University of Augsburg, 
Environmental Science Center, Augsburg, Germany; 4Philips HeartCare Telemedicine Services GmbH, Duesseldorf, Germany; 5Center 
for Environmental Epidemiological Research, Municipal Institute for Medical Research, Universitat Pompeu Fabra, Barcelona, Spain; 
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Background: Epidemiological studies have shown that ambient particulate matter (PM) and 
changes in air temperature are associated with increased cardiopulmonary events.
oBjective: We hypothesized that patients with previous myocardial infarction (MI) experience 
changes in heart rate (HR) and repolarization parameters, such as Bazett-corrected QT interval 
(QTc), and T-wave amplitude (Tamp), in association with increases in air pollution and tempera-
ture changes.
Methods: Between May 2003 and February 2004, 67 MI survivors from the Augsburg KORA-MI 
registry repeatedly sent 16 sec electrocardiograms (ECGs) with a personal transmitter (Viapac) via 
telephone to the Philips Monitoring Center, where ECG parameters were immediately analyzed. 
Meteorological data and air pollutants were acquired from fixed monitoring sites on an hourly basis. 
Additive mixed models were used for analysis. Effect modification by patient characteristics was 
investigated.
results: The analysis of the 1,745 ECGs revealed an increased HR associated with interquartile 
range (IQR) increases in PM levels among participants not using beta-adrenergic receptor blockers 
and among those with body mass index ≥ 30 kg/m2. We observed a 24- to 47-hr lagged QTc pro-
longation [0.5% change (95% confidence interval, 0.0–1.0%)] in association with IQR increases in 
levels of PM ≤ 2.5 µm in aerodynamic diameter, especially in patients with one [0.6% (0.1–1.0%)] 
or two [1.2% (0.4–2.1%)] minor alleles of the nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) 
single-nucleotide polymorphism rs2364725. Positive immediate (0–23 hr) and inverse delayed 
(48–71 hr up to 96–119 hr) associations were evident between PM and Tamp. We detected an 
inverse U-shaped association between temperature and Tamp, with a maximum Tamp at 5°C.
conclusions: Increased air pollution levels and temperature changes may lead to changes in HR 
and repolarization parameters that may be precursors of cardiac problems.
key words: air pollution, air temperature, epidemiology, myocardial infarction, panel study, repo-
larization. Environ Health Perspect 118:1755–1761 (2010). doi:10.1289/ehp.1001995 [Online 
15 September 2010]
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examination, a baseline questionnaire (Peters 
et al. 2007) was administered regarding 
health status, self-report of current medica-
tion intake, and smoking history; blood pres-
sure and body mass index (BMI) also were 
measured. A more detailed description of the 
patient recruitment and the study panel can 
be found elsewhere (Peters et al. 2007).
Clinical measurements. At the begin-
ning of the study, the participants were 
asked whether they wanted to transmit an 
ECG only in case of cardiac symptoms or 
daily at the same time during the whole study 
period. Participants were invited to call the 
Philips Monitoring Center in Düsseldorf, 
Germany, at any time and transmit an ECG 
via telephone (land line or mobile). For this 
purpose, a participant had to fix a 12-lead 
personal ECG transmitter (Philips Viapac, 
Philips Telemedicine and Healthcare Services, 
Dusseldorf, Germany; size ~ 13 × 7 × 5 cm; 
weight, 35 g) with a belt on the chest, which 
placed the electrodes automatically in the cor-
rect position (Mampuya 2002; Mischke et al. 
2005). The medical staff of the monitoring 
center questioned the individuals about car-
diac symptoms and whether they had been in 
traffic or had been exposed to great physical 
strain or anger 2 hr before the transmission. 
The staff, which comprised cardiologists and 
trained medical professionals, immediately 
evaluated the ECG manually.
Each participant repeatedly transmitted 
16 sec ECGs to the monitoring center. If an 
individual sent two ECGs within 30 min, we 
excluded the first measurement assuming that 
the participant thought that the first transmis-
sion was incorrect and hence transmitted a 
second one. If there were several transmis-
sions per day and per patient, only the first 
one (in case of no second transmission within 
30 min) was included in the analysis. ECG 
measurements with a pacemaker rhythm, fre-
quent ectopic ventricular beats, or atrial fibril-
lation were excluded. One individual with 
an internal defibrillator was kept in the study 
because he had a normal heart rhythm with-
out conduction abnormalities during ECG 
transmissions.
The outcomes of interest were HR, QTc, 
Tamp, PQ interval, ST-segment changes, 
and ventricular and supraventricular ectopic 
beats. RR-, QT-, and PQ-interval durations 
were measured manually in lead II. We chose 
lead II for QT measurements because in clini-
cal conditions this lead is considered repre-
sentative of the overall electrical forces of the 
heart. For Tamp, we used ECG leads I, II, 
and V1–V6, and the median value from those 
eight original leads was taken for each car-
diac cycle. For ST-segment leads LII (inferior 
wall), V2 (anterior wall), and V5 (lateral wall) 
were used, respectively, and the ST segment 
was the median value over each 16-sec period.
Genotyping. DNA was extracted from 
ethylenediaminetetraacetic acid anticoagu-
lated blood using a salting out procedure. In 
our analysis, we used 12 SNPs located in four 
genes involved in detoxification pathways. 
The SNPs were rs10183914, rs1806649, 
rs1962142, and rs2364725 in the nuclear 
factor (erythroid-derived 2)-like 2 (NFE2L2) 
gene; rs1048942 and rs2606345 in the cyto-
chrome P450 family 1 member A1 (CYP1A1) 
gene; rs1799945 and rs1800562 in the hemo-
chromatosis (HFE) gene; rs1695, rs6591256, 
and rs4891 in the glutathione S-transferase 
pi (GSTP1) gene; and a deletion in glutathi-
one S-transferase mu 1 (GSTM1). SNPs with 
a minor allele frequency (MAF) < 5% were 
excluded. Each SNP was tested for deviations 
from Hardy-Weinberg equilibrium (HWE). 
For the analyses, SNPs were coded linearly, 
counting the number of minor alleles. For fre-
quencies of rare homozygote genotypes < 5%, 
the hetero- and minor homozygote genotypes 
were combined into one group.
Air pollution and meteorological data. Air 
pollution data from fixed monitoring sites rep-
resenting urban background concentrations 
were collected according to standard proce-
dures (Rückerl et al. 2007). Hourly means 
of carbon monoxide (CO), nitrogen dioxide 
(NO2), and PM with an aerodynamic diameter 
≤ 10 μm or 2.5 μm (PM10, PM2.5) were avail-
able. Particle number concentrations (PNC) 
were obtained as a proxy for ultrafine particles 
(UFP) with an aerodynamic diameter of 0.01–
0.1 μm. Additionally, we computed coarse 
particles (PM10–2.5) as the difference between 
PM10 and PM2.5. Meteorological variables (air 
temperature, relative humidity, barometric 
pressure) were obtained through a monitoring 
system operated by the Bavarian Environment 
Agency (Bayerisches Landesamt für Umwelt).
For each person and ECG transmission, 
we determined average exposures for 0–23 hr 
before ECG transmission and for up to four 
24-hr periods before (24–47, 48–71, 72–95, 
96–119 hr) if more than two-thirds of the 
hourly air pollution or meteorological mea-
surements were available for a given period. 
Additionally, we calculated mean exposures 
during the 5 days (120 hr) before ECG trans-
missions. Missing data on the aggregate level 
were replaced using a formula adapted from the 
APHEA (Air Pollution and Health: A European 
Approach) method (Berglind et al. 2009).
Statistical analysis. The longitudinal data 
were analyzed with the SAS statistical pack-
age (version 9.1; SAS Institute Inc., Cary, 
NC, USA) using additive mixed models with 
a random patient effect. To account for the 
dependencies between the inordinate repeated 
measurements, we assumed a spatial covari-
ance structure. The elements of this covariance 
matrix decline as the elapsed time between 
two measurements increases.
For analysis of air pollution effects, we 
identified confounders for each ECG param-
eter separately. Potential confounders were 
long-term time trend, day of the week, tem-
perature, relative humidity, and barometric 
pressure. The possible lags for meteorology 
were defined as 0–23, 24–47, 48–71, and 
72–95 hr before ECG transmission. The con-
founders were modeled linearly or as penal-
ized splines (P-splines) to allow for nonlinear 
relationships. The lag and shape that mini-
mized the Akaike information criterion (AIC) 
was selected. If a confounder was included as 
a P-spline, we checked whether a polynomial 
led to a smaller AIC. Barometric pressure and 
day of the week were selected only if model fit 
was improved. For the analysis of temperature 
effects, only trend and relative humidity with 
a corresponding lag to the analyzed tempera-
ture lag were included as confounders.
After assessing the confounder model, 
single air pollution or temperature lags were 
added, and the effects were estimated linearly.
SNP selection. The influence of the selected 
SNPs on the mean or variability of the ECG 
parameters was estimated separately. In order 
to assess the association between an SNP and 
variability, mixed models with two differ-
ent covariance structures were calculated. As 
described above, the first model used a spatial 
covariance matrix with blocks identical for each 
participant, but the second model included 
a matrix with three different blocks identical 
only for patients with the same genotype. If the 
likelihood ratio test revealed a significant dif-
ference between the two models, we assumed 
that the variability of the ECG parameter dif-
fered between the genetic groups. For SNP 
selection, the alpha-level was corrected for the 
number of independent tests following a modi-
fied Bonferroni procedure (Li and Ji 2005).
Effect modification. Interaction variables 
were added to the model in order to estimate 
the air pollution or temperature effects of the 
corresponding subgroups. For air pollution, 
separately included interaction variables were 
age (age < 60 vs. ≥ 60 years), BMI (< 30 vs. 
≥ 30 kg/m2), beta-adrenergic receptor block-
ers (intake vs. no intake), sex (women vs. 
men), season (summer April–September vs. 
winter October–March), smoking status (ex-
smoker vs. never-smoker), being in traffic 2 hr 
before the ECG transmission (yes vs. no), and 
SNPs with a significant influence on the mean 
or variability of at least one ECG parameter. 
For temperature, we assessed interactions 
with age, BMI, intake of beta blockers, sex, 
and season. To investigate possible interaction 
effects between exposure variables, we calcu-
lated smooth interaction functions of air pol-
lution and temperature using R version 2.5.0 
(R Foundation for Statistical Computing 
2008). For this purpose, we used the exposure 
lags that showed the strongest associations 
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with the ECG parameters in the performed 
main analyses that included exposure variables 
separately as fixed effects in mixed models.
Sensitivity analyses. In order to check the 
robustness of our models, we performed several 
sensitivity analyses. For air pollution and tem-
perature effect estimation, we excluded ECGs 
with ectopic beats or ECGs transmitted when 
participants indicated they were having cardiac 
problems, respectively. In a further sensitivity 
analysis, individuals with QRS intervals > 120 
msec in at least two ECGs were excluded. 
Furthermore, we performed an alternative con-
founder model including patient characteristics 
such as blood pressure, BMI, sex, smoking sta-
tus, or physical activity if this minimized the 
AIC. Afterward, the meteorological confound-
ers were selected as described above. Because 
PNC was not measured for several weeks dur-
ing the study period, we additionally estimated 
the association between PM or gaseous pollut-
ants and ECG parameters only on days with 
existing PNC measurements.
For temperature effect estimation we 
added barometric pressure, PM10, or PM2.5 
separately to the original confounder model. 
Barometric pressure was included with the 
same lag as the analyzed temperature lag. PM 
was included either with the same lag as tem-
perature or with the lag exhibiting the largest 
association with the outcome in the air pol-
lution analysis. The shape (linear, smooth, 
polynomial) of barometric pressure and air 
pollutants that minimized AIC was chosen, 
respectively. Additionally, temperature effects 
were estimated as P-splines.
Results
Study population. A total of 75 individuals 
participated in the substudy and received a 
Viapac system from Philips. Two patients 
were ineligible because they had not had a 
previous MI according to the official crite-
ria; we excluded five patients because they 
did not transmit any ECG or transmitted 
only one ECG to the monitoring center. We 
excluded individual ECG measurements for 
the following reasons: abnormal pacemaker 
rhythm or ventricular trigeminus (51 ECGs 
from 3 patients), atrial fibrillation (37 ECGs 
from 5 patients), transmission while not in 
Augsburg (14 ECGs from 10 patients) or 
from an unknown location (2 ECGs from 
2 patients), second ECG transmitted within 
30 min (3 ECGs from 3 patients), and sec-
ond ECG transmission within 1 day but 
not within 30 min of another transmission 
(14 ECGs from 9 patients). We excluded one 
patient because only one eligible ECG was 
available after we excluded a second ECG 
due to atrial fibrillation. Therefore, 1,745 
ECGs from 67 patients were available for the 
analyses. Only 3 of 21 persons who agreed to 
transmit ECGs on a daily basis did so; 46 per-
sons declared intention to transmit ECGs 
only in case of cardiac problems. However, 
in both groups only 16 ECGs (2%) were sent 
due to heart trouble, respectively. The par-
ticipants transmitted on average 26 ECGs 
(range, 3–178 ECGs) and experienced an MI 
on average 2.2 years (range, 0.6–3.5 years) 
before study entry. The age of the participants 
ranged from 40 to 76 years. In Table 1, we 
provide further clinical patient characteristics.
Clinical measurements. Table 2 describes 
the ECG parameters analyzed. HR, QTc, 
Tamp, and PQ interval were not correlated 
according to the median of patient-specific 
Spearman correlation coefficients (data not 
shown). We did not evaluate ST-segment 
changes because they were available for 
only 72 ECGs (4%). We did not analyze 
ectopic beats because only 76 ECGs (4%) 
from 19 participants and 31 ECGs (2%) 
from 12 participants exhibited ventricular and 
supraventricular ectopic beats, respectively.
Air pollution and meteorological data. 
During the study period the 24-hr aver-
ages ± SD were 33.4 ± 13.2 μg/m3 for 
PM10, 15.8 ± 7.7 μg/m3 for PM10–2.5, 
17.7 ± 6.2 μg/m3 for PM2.5, 11,809 ± 
6,253/cm3 for PNC, 40.7 ± 10.8 μg/m3 
for NO2, 0.6 ± 0.2 mg/m3 for CO, 10.8 ± 
9.9°C for air temperature, 69.1 ± 14.5% for 
relative humidity, and 1018.2 ± 6.9 hPa for 
barometric pressure [for additional informa-
tion, see Supplemental Material, Table 1 
(doi:10.1289/ehp.1001995)]. Spearman cor-
relation coefficients among the three PM 
measurements and between CO and PNC, 
PM10–2.5 and NO2, and temperature and rel-
ative humidity revealed moderate or strong 
correlations (|r| > 0.5). The remaining air pol-
lutants and meteorological covariates were not 
correlated. Supplemental Material, Figure 1 
(doi:10.1289/ehp.1001995), depicts daily 
24-hr averages of PM2.5, PNC, and tempera-
ture during the study period. About 29% of 
the PNC measurements and ≤ 2% of all other 
air pollution and meteorological variables were 
missing due to a device failure.
Estimated effects of air pollution. Table 3 
shows the percent changes in arithmetic mean 
values of the ECG parameters [with 95% 
confidence intervals (CIs)] per interquartile 
range (IQR; difference between the third and 
first quartile) increase in PM and PNC. IQR 
increases in PM levels were associated with 
significant increases in QTc 24–47 hr later, 
and borderline significant increases in QTc 
were associated with 48- to 71-hr lag and 
5-day average PM10 and PM2.5 levels. IQR 
increases in CO concentrations were also asso-
ciated with QTc prolongation [0.4% (95% CI, 
0.1–0.7%)] 24–74 hr later (data not shown). 
In general, Tamp was positively associated 
with air pollution levels 0–23 hr and 24–47 hr 
before ECG transmission and inversely associ-
ated with levels more than 48 hr before, with 
a significant positive association with PM2.5 
0–23 hr before and a significant inverse asso-
ciation with PM10–2.5 96–119 hr before trans-
mission (Table 3). In addition, Tamp was 
positively associated with NO2 0–23 hr [3.0% 
(0.2–5.7%)] and 24–47 hr [3.1% (0.1–6.1%)] 
before transmission. We observed no signifi-
cant associations between air pollutants and 
HR (Table 3) or PQ interval (data not shown).
Table 1. Description of the study population of 
67 participants with at least one MI.
Clinical characteristic
Mean ± SD 
or total (%)
Age (years) 59.3 ± 8.5
BMI (kg/m2) 29.0 ± 4.3
Systolic blood pressure (mmHg) 127.7 ± 19.9
Diastolic blood pressure (mmHg) 77.7 ± 10.5
Sex (men) 58 (87)
BMI (kg/m2)
< 30 42 (63)
≥ 30 25 (37)
ECG transmission time period
Winter (October–March) 791 (45)
Summer (April–September) 954 (55)
Type 2 diabetes mellitus 9 (13)
First MI 59 (87)
Angina pectoris 14 (21)
Arrhythmias 15 (22)
Congestive heart failure 6 (9)
Hypertension 28 (42)
Occupational status
Full-time or part-time employment 29 (43)
Exposed to toxic gases, dust, or fumes 
during work
15 (22)
Smoking 
Never-smoker 14 (21)
Ex-smokera 53 (79)
Current medication intake
Beta blockers 62 (93)
Angiotensin-converting enzyme 
inhibitors
48 (72)
Calcium-channel blockers 8 (12)
Nitrates 9 (13)
Statins 59 (88)
Diuretics 22 (32)
Acetylsalicylic acid 61 (91)
Other antithrombotics 7 (10)
All patient characteristics were determined with a ques-
tionnaire during a clinical examination. 
aHad stopped smoking at least 3 months before start of 
the study.
Table 2. Description of ECG parameters.
ECG parameter n Mean ± SD Minimum 25% Median 75% Maximum IQR
HR (beats/min) 1,745 71.5 ± 11.6 40 63 71 79 114 16
QTc (msec) 1,744 400.6 ± 32.6 270 380 400 420 560 40
Tamp (µV) 1,743 213.4 ± 154.8 –200 100 200 300 700 200
PQ interval (msec) 1,743 164.1 ± 27.8 110 140 160 180 290 40
25% and 75% are 25th and 75th percentiles, respectively.
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Estimated effects of air temperature. HR, 
QTc, and PQ interval were not associated 
with temperature changes (data not shown), 
but we observed an inverse U-shaped asso-
ciation between temperature and Tamp 
with highest Tamp at 5°C (Figure 1A). To 
obtain separate temperature effect estimates 
for warmer and colder days, we modeled 
temperature as a linear variable and added 
an interaction term between temperature 
and a variable indicating mean temperature 
above or below 5°C. For all lags we observed 
a 5–9% decrease in Tamp associated with a 
temperature decline of 5°C on days with aver-
age temperatures < 5°C (cold effects) and with 
a 5°C increase in temperature on days > 5°C 
(heat effects; Figure 1B).
Effect modification. HR significantly 
increased in association with an IQR increase 
in PM2.5 0–23 hr before ECG transmission 
in individuals with BMI ≥ 30 kg/m2 [1.8% 
(0.4–3.1%)] and in individuals not using 
beta blocker medication [2.4% (0.4–4.5%); 
Figure 2]. These effect modifications were 
significant (p-value < 5%) for BMI but only 
borderline significant for intake of beta block-
ers. However, only five participants with 200 
ECGs did not take beta blockers. No sig-
nificant interactions between PM and BMI or 
intake of beta blockers were evident for QTc. 
Tamp was significantly increased in associa-
tion with an IQR increase in PM2.5 0–23 hr 
before ECG transmission in participants with 
a BMI < 30 kg/m2 and in patients taking beta 
blocker medications. However, the inter action 
effects were not significant. Additionally, we 
observed a positive association between Tamp 
and an IQR increase in CO 24–47 hr before 
ECG transmission among participants with 
BMI < 30 kg/m2 [2.7% (0.5–4.8%)] and 
inverse associations with CO among those 
with BMI ≥ 30 kg/m2 [–3.7% (7.4–0.0%)].
We did not evaluate associations with 
rs18005862 in HFE and rs1048943 in 
CYP1A1 because MAFs were < 5%. Although 
rs10183914 in the NFE2L2 gene was not 
in HWE, we did not exclude it because our 
study comprises a highly selected group of 
MI survivors and not a random population 
sample. We corrected the global significance 
level of 5% for testing associations between 
SNPs and mean levels or variability of ECG 
parameters for the 8 independent tests result-
ing in an adjusted alpha-level of 0.05/(8 × 2) 
= 0.003125. No SNP was significantly associ-
ated with mean levels of ECG parameters 
(data not shown), but some were significantly 
associated with variability in ECG param-
eters [see Supplemental Material, Table 2 
(doi:10.1289/ehp.1001995)].
We detected interaction effects between 
particulate air pollutants and genotypes 
only for rs2364725 in the NFE2L2 gene 
on QTc (Figure 3). Nineteen participants 
with 363 ECGs were homozygous carriers 
of the minor allele (G), 28 participants with 
885 ECGs were heterozygous, and 20 par-
ticipants with 497 ECGs were homozygous 
carriers of the major allele (T). IQR increases 
in PM 24–47 hr before ECG transmission 
were associated with a prolonged QTc of 
about 0.5–1.5% only in patients with at least 
one minor allele. We also observed a simi-
lar pattern for PM exposures 0–23 hr before 
ECG transmission (data not shown). An IQR 
increase in PNC exposure 96–119 hr before 
transmission was inversely associated with 
QTc in patients with one or two minor alleles 
[–0.8% (–1.5 to –0.1%) and –2.2% (–3.4 to 
–1.0%), respectively] but not in other patients 
[0.6% (–0.4 to 1.6%)].
We detected no other significant air pollu-
tion effect modifications with other variables. 
Temperature effects were not modified by any 
variable (data not shown).
Sensitivity analyses. After excluding 10 
patients having at least two ECGs with QRS 
intervals > 120 msec the air pollution asso-
ciations were in general slightly more pro-
nounced (data not shown). We observed an 
immediate and 24- to 47-hr lagged increase 
in HR of about 1% in association with 
PM. None of the other sensitivity analyses 
resulted in any notable changes in associations 
between air pollutants or temperature and the 
outcomes. We found no evidence for a devia-
tion of linearity of temperature effects on HR 
or QTc.
Discussion
Our analyses showed no main effects of air 
pollutants on HR overall, but we observed 
significant positive associations between PM 
0–23 hr before and HR among participants 
with BMI ≥ 30 kg/m2 and among those not 
using beta blocker medications. We observed 
Figure 1. P-spline of air temperature in association with Tamp (A) and mean change in Tamp (with 95% CIs) 
associated with a 5°C increase or decrease in air temperature on days with average air temperature above 
or below 5°C, respectively (B). Both A and B are adjusted for long-term time trend and relative humidity.
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Table 3. Percent change of the outcome mean per IQR increase in pollutant.
Hr before transmission
Estimate (95% CI)
PM10a (µg/m3) PM10–2.5b (µg/m3) PM2.5c (µg/m3) PNCd (/cm3)
HR
0–23 hr 0.4 (–0.3 to 1.2) 0.2 (–0.5 to 1.0) 0.5 (–0.2 to 1.2) –0.4 (–1.2 to 0.5)
24–47 hr 0.5 (–0.3 to 1.3) 0.5 (–0.2 to 1.3) 0.5 (–0.2 to 1.1) –0.6 (–1.4 to 0.3)
48–71 hr 0.2 (–0.6 to 0.9) 0.1 (–0.6 to 0.9) 0.1 (–0.6 to 0.8) –0.7 (–1.5 to 0.1)
72–95 hr 0.3 (–0.5 to 1.1) 0.3 (–0.5 to 1.0) 0.2 (–0.5 to 1.0) –0.4 (–1.2 to 0.5)
96–119 hr –0.1 (–0.9 to 0.7) 0.1 (–0.7 to 0.9) –0.2 (–0.9 to 0.6) –0.5 (–1.5 to 0.4)
5-day average 0.3 (–0.3 to 1.0) 0.4 (–0.3 to 1.1) 0.3 (–0.4 to 1.0) –1.2 (–2.6 to 0.1)*
QTc
0–23 hr 0.2 (–0.4 to 0.7) 0.0 (–0.5 to 0.5) 0.3 (–0.2 to 0.8) 0.0 (–0.6 to 0.6)
24–47 hr 0.7 (0.2 to 1.2)** 0.8 (0.3 to 1.3)** 0.5 (0.0 to 1.0)** 0.5 (–0.1 to 1.0)
48–71 hr 0.4 (–0.1 to 0.9)* 0.4 (–0.1 to 0.9) 0.4 (0.0 to 0.9)* 0.2 (–0.4 to 0.8)
72–95 hr 0.3 (–0.2 to 0.8) 0.3 (–0.2 to 0.8) 0.3 (–0.2 to 0.8) 0.1 (–0.5 to 0.7)
96–119 hr 0.3 (–0.2 to 0.8) 0.3 (–0.3 to 0.8) 0.3 (–0.2 to 0.8) –0.6 (–1.3 to 0.1)
5-day average 0.4 (0.0 to 0.8)* 0.4 (0.0 to 0.8)* 0.4 (0.0 to 0.9)* 0.2 (–0.8 to 1.1)
Tamp
0–23 hr 3.3 (0.0 to 6.5)* 2.9 (–0.3 to 6.0)* 3.3 (0.2 to 6.3)** 1.7 (–1.7 to 5.1)
24–47 hr 3.0 (–0.4 to 6.4)* 2.5 (–0.8 to 5.8) 2.8 (–0.3 to 5.9)* 2.8 (–0.6 to 6.1)
48–71 hr –0.8 (–4.1 to 2.4) –0.8 (–4.0 to 2.3) –0.5 (–3.5 to 2.5) –2.4 (–6.1 to 1.3)
72–95 hr –1.8 (–5.1 to 1.4) –2.1 (–5.4 to 1.1) –1.3 (–4.2 to 1.6) –3.0 (–6.7 to 0.7)
96–119 hr –2.3 (–5.5 to 0.9) –3.2 (–6.4 to –0.1)** –0.9 (–3.8 to 2.0) –0.8 (–4.6 to 2.9)
5-day average 0.1 (–2.8 to 3.0) –0.5 (–3.4 to 2.5) 0.8 (–2.3 to 4.0) –0.7 (–7.0 to 5.6)
aIQR 24-hr average, 19.5 µg/m3; IQR 5-day average, 11.9 µg/m3. bIQR 24-hr average, 10.9 µg/m3; IQR 5-day average, 
6.5 µg/m3. cIQR 24-hr average, 8.4 µg/m3; IQR 5-day average, 6.3 µg/m3. dIQR 24-hr average, 7,481/cm3; IQR 5-day aver-
age, 6,974/cm3. *p < 0.1. **p < 0.05.
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a prolonged QTc interval in association 
with increases in PM levels 24–47 hr before 
ECG transmission, with stronger associations 
among participants with one or two minor 
alleles of the NFE2L2 SNP rs2364725. 
However, patients with at least one minor 
allele showed shortened QTc in association 
with an increase in PNC 96–119 hr before. 
Tamp decreased in association with both 
cold and warm temperatures, with maximum 
Tamp around 5°C.
Air pollutants and ECG parameters. 
Several authors have reported inverse asso-
ciations between air pollutants and HRV in 
the elderly (Luttmann-Gibson et al. 2006; 
Schwartz et al. 2005). It is hypothesized 
that air pollutants may activate the sympa-
thetic nervous system directly or indirectly, 
which possibly leads to an increased HR and 
reduced HRV. UFP might even translocate 
into the systemic circulation and affect the 
electric system of the heart directly (Pope 
and Dockery 2006). It has been shown that 
patients not using beta blocker medications 
exhibit a stronger reduction in HRV in asso-
ciation with PM exposure compared with 
patients using beta blockers (de Hartog et al. 
2009). We observed an increased HR with 
exposure to air pollutants only among our 
patients with 200 ECGs not using beta block-
ers. Beta blockers constrain the activation of 
the sympathetic tone; thus, participants using 
beta blockers might be less susceptible to acti-
vation of the sympathetic nervous system by 
air pollutants. Because of the small number of 
participants not taking beta blockers and even 
if patient characteristics did not differ signifi-
cantly between individuals with and without 
beta blocker intake, it is still possible that the 
observed differences in the estimated air pol-
lution effects are related to something other 
than medication intake. Consistent with our 
findings, Chen et al. (2007) reported stronger 
positive associations between PM2.5 and HR 
in individuals with BMI ≥ 30 kg/m2.
Henneberger et al. (2005) detected an 
immediate positive association of 24-hr aver-
ages of organic carbon with QTc. Furthermore, 
Liao et al. (2010) reported immediate and 
delayed QTc prolongations associated with 
elevated 30-min averages of PM2.5. However 
Lux and Pope (2009) observed no association 
between PM2.5 and repolarization param-
eters in elderly participants. In our analysis we 
found lagged associations between PM and 
QTc. Associations were more pronounced 
among participants with one or two minor 
alleles of the NFE2L2 SNP rs2364725. The 
NFE2L2 gene is believed to be involved in the 
defense against oxidative stress (Goldring et al. 
2004). We can only speculate that the defense 
is more activated in patients with common 
alleles, whereas patients with at least one minor 
allele are more susceptible to PM. In contrast, 
we observed inverse associations between 
QTc and PNC, a proxy for UFP, in accor-
dance with two chamber studies (Samet et al. 
2009; Zareba et al. 2009) that reported QTc 
shortening in healthy nonsmoking subjects 
who were exposed to UFP. Different effects 
of PM and PNC might reflect different bio-
logical pathways activated by different particle 
properties. Tamp indicates the repolarization 
of the ventricles and Henneberger et al. (2005) 
reported a 7.3% decrease in Tamp in asso-
ciation with an increase in UFP 0–23 hr before 
ECG measuring. A subsequent analysis of Yue 
et al. (2007) suggested that this association 
was driven by traffic-related UFP specifically. 
We observed a 4-day delayed decrease and an 
immediate elevation of Tamp in relation with 
all PM parameters which cannot be explained 
by a single patient characteristic such as BMI. 
It can only be speculated that a combination of 
medication intake and disease history may be 
involved in the susceptibility to air pollution. A 
study by Schneider et al. (2010) also observed 
opposed variations in Tamp responses depend-
ing on the considered PM2.5 lag. In general, 
changes in repolarization might be the result of 
changes in the ion channel function or a direct 
effect of the autonomic nervous system on the 
ventricular myocardium (Ghelfi et al. 2008; 
Henneberger et al. 2005; Zareba et al. 2009). 
However, the understanding of the complex 
biologic pathways is still very limited.
It has been shown that T-wave altern-
ans (TWA) is a reliable predictor for sudden 
cardiac death (Stein et al. 2010). Zanobetti 
et al. (2009) observed an association between 
black carbon and TWA in CAD patients. 
Prolonged QTc are a risk factor for cardiac 
arrhythmia (Roden 2008) and cardiovascular 
mortality (Ziegler et al. 2008). Our results 
suggest that elevated levels of air pollutants 
might trigger changes in Tamp and QTc and 
therefore might predispose to additional car-
diovascular problems in individuals who had 
already experienced an MI.
Temperature and ECG parameters. 
Yamamoto et al. (2007) found increased 
HR and decreased HRV after exposing six 
healthy Japanese to a heated condition (37°C) 
in a chamber study. Bruce-Low et al. (2006) 
observed similar results among participants 
with ECG measurements before and during 
exposure to heat in a sauna. In our analyses, 
HR did not appear to be altered by tempera-
ture changes, but during the study period 
24-hr averages of temperature never exceeded 
28°C, which is similar to the temperature 
Figure 3. Associations between IQR increases in 
PM and QTc (lag, 24–47 hr) according to minor 
allele frequencies of NFE2L2 rs2364725 (T, wild-
type allele; G, minor allele; adjusted for long-term 
time trend and meteorology; IQRs: PM10, 19.5 µg/m3; 
PM10–2.5, 10.9 µg/m3; PM2.5, 8.4 µg/m3).
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conditions before heat exposure in the previ-
ously described studies.
Several studies reported a U- or J-shaped 
influence of apparent temperature on cardio-
respiratory mortality; the lowest mortality 
was observed for temperatures between 15 
and 25°C (Baccini et al. 2008; McMichael 
et al. 2008). However, Baccini et al. (2008) 
conducted their study only in the summer, 
whereas our study took place during almost 
1 year with low temperatures during the 
winter. A study conducted by McMichael 
et al. (2008) also included Asian and South 
American cities with high mean temperatures.
Lin et al. (2008) reported an increased risk 
of cardiovascular events during a follow-up of 
30 days among patients with T-wave flat-
tening at the time of the emergency depart-
ment visit. In our study Tamp decreased with 
temperature increases as well as decreases. 
Wolf et al. (2009) observed an inverse rela-
tion between temperature and MI occurrence. 
Therefore, temperature might act as a trig-
ger for T-wave flattening in susceptible indi-
viduals, leading to an enhancement of already 
existing cardiovascular problems.
Because core temperature should not be 
affected by small changes in ambient tempera-
ture, we can only speculate that our observed 
associations are probably affected by changes 
in the autonomic nervous system or by load-
ing effects on the heart possibly mediated by 
cutaneous blood flow regulation or neural 
input from temperature sensors in the skin.
Strengths and limitations. A strength of 
this study is the ability to analyze intraindi-
vidual variation because patients transmitted 
ECG parameters on several occasions. Further 
strengths are the nonlinear confounder adjust-
ment and the detailed information on patient 
characteristics and SNPs allowing us to per-
form several subgroup analyses. Because our 
estimated effects remained stable in several sen-
sitivity analyses, our results seem to be quite 
robust. Cardiac arrhythmias alter the inter-
pretation of the ECG parameters; therefore, 
to have a homogeneous ECG data set, we 
excluded ECGs with pacemaker rhythms, ven-
tricular trigeminus, or atrial fibrillation. One 
limitation is that we measured only outdoor 
exposure, whereas in general people spend a 
lot of time indoors. However, a study of Cyrys 
et al. (2004) revealed that ambient concentra-
tions of PM2.5 and black smoke can be used 
as good approximation of indoor concentra-
tions. However, personal measurements of 
air pollutants should be taken into account 
in future studies if possible. Because several 
studies (Analitis et al. 2008; Zanobetti and 
Schwartz 2008) have shown that changes in 
temperature are associated with increases in 
cardiovascular mortality, we assumed that also 
a short exposure to outdoor temperature pos-
sibly influences ECG parameters. A variety 
of exposure and outcome variables have been 
used for the analyses, so we cannot exclude that 
some associations occurred only by chance. A 
further limitation is that our panel comprised 
a highly selected group of MI survivors who 
were taking a variety of medications and might 
have different reactions to air pollution and 
temperature compared with healthy people. 
Thus, generalizability of our results is uncer-
tain. On the other hand, analyzing vulnerable 
patients might give better insight into possible 
mechanistic pathways
Conclusion
Our results indicate that IQR increases in air 
pollutants were associated with an increase in 
mean HR among MI patients with BMI ≥ 30 
kg/m3 and among those not using beta block-
ers. We observed QTc prolongation in associ-
ation with an IQR increase in PM in patients 
with at least one minor allele of a NFE2L2 
SNP. We detected inconsistent associations 
between air pollution and Tamp, and nonlin-
ear associations between ambient temperature 
and Tamp. Overall, we observed changes in 
HR and repolarization parameters associated 
with air pollutant exposures and temperature 
changes that are possible precursors for addi-
tional cardiovascular problems in individuals 
who had already experienced an MI.
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Supplemental Material, Table 2. SNPs with a significant influence on the
variability of ECG parameters.
Minor Major Distribution in study population  
N (%) 
Outcome Gene SNP 
allele Homozygous 
minor allele
Heterozygous Homozygous 
major allele 
MAF 
% 
p-value*
HR  NFE2L2  rs1962142 A G 0 (0) 20 (30) # 67 (70) 14.9 1.57E-04
          
QTc NFE2L2  rs10183914 T C 9 (13) # 25 (37) 33 (49) 32.1 4.77E-04
 NFE2L2  rs2364725 G T 19 (28) 28 (42) 20 (30)# 49.3 6.78E-07
  HFE rs1799945 G C 1 (2) 16 (24) 49 (74)# 13.6 2.11E-04
          
Tamp NFE2L2  rs10183914 T C 9 (13) 25 (37)# 33 (49) 32.1 1.59E-06
 NFE2L2  rs1806649 T C 6 (9) 22 (33)# 39 (58) 25.4 4.44E-16
 NFE2L2 rs1962142 A G 0 (0) 20 (30)# 67 (70) 14.9 7.15E-09
 NFE2L2  rs2364725 G T 19 (28) 28 (42) 20 (30)# 49.3 3.04E-14
 GSTM1  - - - - -** 45.3*** 4.44E-15
 GSTP1 rs4891 C T 8 (12) 30 (45)# 29 (43) 34.3 1.31E-06
 GSTP1  rs1695 G A 7 (10) 29 (29)# 31 (46) 32.1 2.92E-07
 GSTP1  rs6591256 G A 15 (22) 31 (46) 21 (31)# 45.5 2.22E-16
 CYP1A1  rs2606345 C A 4 (6)# 31 (46) 32 (48) 29.1 5.47E-06
SNP: Single nucleotide polymorphism, MAF: minor allele frequency, HR: Heart rate, QTc: Bazett-corrected QT-interval, Tamp: T-
wave amplitude, #Indicates subgroup with highest variability in ECG parameter, *Taking multiple testing into account led to a 
significance level of 0.003125, **Homozygote carriers of deletion showed a higher variability in Tamp, **Percentage of homozygote 
carriers of deletion 
 
41
Supplemental Material, Figure 1. Time series of PM2.5, PNC and air tem-
perature in Augsburg, Germany between May 30th 2003 and February 1st
2004 (PM2.5: particulate matter with a diameter below 2.5µm, PNC: particle
number concentration with a size range of 0.01 to 0.1µm in diameter).
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ABSTRACT
Background. Epidemiological studies have shown associations between par-
ticulate matter (PM) and heart rate variability (HRV).
Objectives. We investigated the effects of air pollution on the root mean
square of successive differences in RR intervals (RMSSD) and the standard
deviation of NN-intervals (SDNN) and effect modifications by single nu-
cleotide polymorphisms (SNP).
Methods. Between March 2007 and December 2008 207 ECG recordings
comprising 1153 1h-intervals were measured in 61 individuals with type 2
diabetes mellitus or impaired glucose tolerance (IGT) from Augsburg, Ger-
many. Associations between 1h-averages of air pollutants (PM, sulphate,
black carbon, and ultrafine particles) and ECG parameters were analyzed
using additive mixed models. Genotypes of 139 SNPs supposed to be in-
volved in cardiac rhythm were identified in the literature. Using regression
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trees for longitudinal data, SNPs associated with ECG parameters were de-
termined and included as potential air pollution effect modifiers.
Results. We observed concurrent and lagged decreases in SDNN by about
2-5% in association with all air pollutants, especially in participants with
at least one minor allele of rs332229. Increases in PM< 2.5µm (PM2.5) were
associated with 4h-lagged decreases of -6.6% [95%-confidence interval: -10.6;-
2.6%] and -13.0% [-20.7;-5.1%] in SDNN in individuals with one or two minor
alleles, respectively. We observed a -7.2% [-12.2;-1.8%] reduction in RMSSD
associated with concurrent increases in PM2.5. Individuals with at least one
minor allele of rs2096767 or at most one minor allele of rs2745967 exhibited
stronger PM2.5 effects.
Conclusions. We identified a genetic predisposition in persons with dia-
betes or IGT making them potentially more susceptible to air pollutants
with regard to changes in HRV.
INTRODUCTION
Initially, Pope et al. (1999), Peters et al. (1999), and Gold et al. (2000)
reported associations between elevated air pollution levels and increases in
heart rate (HR) and decreases in heart rate variability (HRV). Recent studies
were able to confirm changes in heart rhythm. For instance, researchers ob-
served decreased time and frequency domain parameters in association with
elevated air pollution levels in patients with coronary artery disease (CAD)
(Zanobetti et al. 2010), in individuals with metabolic syndrome (Min et al.
2009; Park et al. 2010), and in healthy participants (Wu et al. 2010). It is as-
sumed that the observed findings might be a consequence of 1) an imbalance
of the autonomic nervous system, 2) a direct affection of the electric system
of the heart, or 3) a systemic inflammation and oxidative reaction promoting
vascular dysfunction (Brook et al. 2010; Pope and Dockery 2006). Individ-
uals with diabetes mellitus type 2 (DMT2) are supposed to be a susceptible
population. Peel et al. (2007) and Zanobetti and Schwartz (2001), for exam-
ple, observed an increased risk for emergency department visits and hospital
admissions in association with air pollution increases in diabetes patients,
respectively. Diabetes can cause autonomic neuropathy leading to a reduced
HRV (Kudat et al. 2006); Park et al. (2005) observed a stronger reduction in
some HRV parameters in association with particulate air pollution increases
in DMT2 individuals compared to people without DMT2.
Ambient air pollution may act on the autonomic function via oxidative stress
pathways (Brook et al. 2010). Therefore, not only people with DMT2 might
be susceptible to air pollution but also people with genetic predispositions
related to these pathways. Accordingly, authors observed modifications of
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air pollution effects on HRV parameters by oxidative stress-related single nu-
cleotide polymorphisms (SNP) (Chahine et al. 2007; Schwartz et al. 2005).
It has also been reported that HR and HRV (Eijgelsheim et al. 2010; Newton-
Cheh et al. 2007) as well as repolarization parameters (Chambers et al. 2010;
Pfeufer et al. 2009) are modulated by variants in genes. We hypothesized
that people with an altered cardiac rhythm due to genetic predispositions
might also show different reactions to air pollution exposure. Therefore,
we investigated the modification of air pollution effects on HRV parameters
by SNPs involved in cardiac rhythm in potentially susceptible participants
with DMT2 or impaired glucose tolerance (IGT) indicating an enhanced risk
for DMT2. In contrast to already published studies (Chahine et al. 2007;
Probst-Hensch et al. 2008; Schwartz et al. 2005) which used single candidate
SNPs as potential effect modifiers we performed, in a first step, regression
trees for longitudinal data in order to identify SNPs with an influence on
repeated measurements of ECG parameters. Only these influential SNPs
were then used as potential effect modifiers. The main advantage of this
procedure was that we reduced the number of performed tests. Moreover,
with this method we were able to select more than 130 SNPs from published
genome-wide association studies (GWAS) and did not have to restrict our
analysis to only a few candidate SNPs.
MATERIALS AND METHODS
Study design and study population
As part of the University of Rochester Particulate Matter Center investiga-
tions, a prospective panel study was conducted between March 19th 2007
and December 17th 2008 in Augsburg, Germany. Individuals with DMT2
or IGT were recruited from the KORA (Cooperative Health Research in the
Region of Augsburg) F4 cohort which was conducted in the years 2006-2008
and also serves as study sample for genome-wide analysis (Holle et al. 2005;
Wichmann et al. 2005). In our study, all individuals participated in up to
four repeated ECG recordings scheduled every 4-6 weeks on the same week-
day and at the same time of the day. Data on health status, medication as
well as disease and smoking history were gathered at a baseline visit. Exclu-
sion criteria were current smoking, intake of platelet aggregation inhibitors
except for acetylsalicylic acid, a myocardial infarction (MI) and/or interven-
tional procedure (PTCA, bypass surgery) less than six months before the
start of the study, chronic inflammatory diseases, an implanted pacemaker,
atrial fibrillation, allergy to latex, and thrombosis or shunt in an arm. All
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participants gave written informed consent and the study protocol was ap-
proved by the Ethics Commission of the Bavarian Chamber of Physicians
(”Bayerische Landesaerztekammer”).
Clinical measurements
Participants were equipped with a 12-lead Mortara H12 digital Holter recorder
(Mortara Instrument, Milwaukee, WI, USA). They left the study center to
pursue their daily routines and returned after four to six hours. ECG pa-
rameters such as HR, repolarization, and HRV time and frequency domain
parameters were determined on an hourly basis. Therefore, repeated ECG
recordings for each participant and repeated 1h-averages of ECG parameters
within one recording were available. Only individuals with at least one ECG
recording with a duration of at least two hours were used for analysis.
Genotyping
Genome-wide data were available for each individual based on MACH im-
putation of Affymetrix 6.0 genotyped data (see Supplement Material). For
our analysis we only used SNPs supposed to be involved in cardiac rhythm
(e.g. HR, RMSSD, high and low frequency, and PR- and QT-interval) which
were already identified in the literature and published before August 2010.
SNPs were coded counting the number of minor alleles. We tested for ev-
idence against the additive genetic model using a procedure introduced by
Schaid et al. (Schaid 2004). For our analysis we excluded SNPs in case of
a minor allele frequency below 5%, an imputation quality (observed vs. ex-
pected variance of the genotypes as returned as measure RSQR by MACH)
below 0.6 potentially indicating a deviation from Hardy-Weinberg equilib-
rium (HWE), or a significant deviation from the additivity assumption. If
less than three participants with DMT2 or IGT exhibited a homozygote mi-
nor allele frequency we combined the hetero- and rare homozygous frequency
of the respective SNP into one group. See Supplemental Material for a more
detailed description of the genetic data.
Air pollution and meteorology data
Amongst others, hourly means of air temperature, relative humidity, baro-
metric pressure, particulate matter (PM) with an aerodynamic diameter be-
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low 10µm or 2.5µm (PM10, PM2.5), ultrafine particles (UFP) with a size
range of 0.01 to 0.1µm in diameter, and sulfate and black carbon (BC) mass
concentration of PM2.5 were measured at a central measurement site in Augs-
burg throughout the complete study period as described previously (Cyrys
et al. 2008b; Pitz et al. 2008). For a more detailed description of the air pol-
lution measurement and the replacement of missing values see Supplemental
Material.
Statistical analysis
Influential SNPs
In a first step, we conducted a literature research and identified SNPs which
have already been shown to modulate repolarization and HRV parameters.
In order to determine the influence of SNPs on ECG parameters we used re-
gression trees for longitudinal data implemented in the R package REEMtree
(Sela and Simonoff 2010). This method alternates between estimating the
regression tree, assuming that the previously estimated random effects of
a mixed model are correct, and estimating the random effects, using the
information of the regression tree performed in the prior step. In general,
a regression tree is a non-parametric method which performs binary recur-
sive partitioning dividing the outcome variable in homogeneous subgroups
by using covariable information (Breiman et al. 1983). For each ECG pa-
rameter we estimated regression trees for longitudinal data always excluding
one single ECG recording in order to check the robustness of the trees. SNPs
which occurred at least in 75% of all trees were used to assess a potential
modification of the air pollution effect.
Air pollution effects
Air pollution effects were estimated with SAS statistical package (version
9.2; SAS Institute Inc., Cary, NC, USA) using additive mixed models with a
random participant effect. A first order autoregressive covariance structure
has been proved to be sufficient to account for the dependencies between the
repeated ECG recordings.
A confounder selection was conducted for each ECG parameter separately.
Potential confounders were long-term time trend, time of the day, day of the
week, air temperature, relative humidity, and barometric pressure. Possi-
ble lags considered for meteorology were the 1h-averages concurrent to the
1h-ECG recordings, 1h-averages 1h up to 12h, and 24h-averages 0-23h and
24-47h before each 1h-ECG interval. The confounders were included linearly
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or smoothly as penalized splines (P-Splines) to allow for a non-linear relation-
ship. The lag and shape which minimized the Akaike Information Criterion
(AIC) was selected. If a confounder was included as P-Spline, we checked
whether a polynomial led to a smaller AIC. Barometric pressure, time of the
day, and day of the week were only selected in case of model fit improvement.
After assessing the confounder model, 1h-averages of air pollutants concur-
rent to the 1h-averages of ECG measurements and up to 6h before the ECG
recordings were separately added to the confounder model and the effects
were estimated linearly. In a further analysis, influential SNPs identified
with regression trees were used as air pollution effect modifiers. Addition-
ally, main effects and effect modifications on ECG parameters were calculated
for participants with DMT2 and IGT separately.
Sensitivity analyses
As sensitivity analysis air pollution effects were estimated smoothly as P-
Splines in order to check the linearity of the relationship between air pollu-
tants and ECG parameters. Furthermore, we excluded ECG recordings of
occasional smokers and of participants who reported that they have been ex-
posed to environmental tobacco smoke (ETS) during the recording. We also
excluded individuals with CAD, angina pectoris, or a MI. Additionally, we
only included participants without intake of beta-adrenergic receptor block-
ers (beta-blockers).
RESULTS
Study population and clinical measurements
Overall, 61 participants with 207 valid ECG recordings (average duration:
5.6h) comprising 1153 1h-intervals were available for analysis. Table 1 de-
scribes the baseline characteristics of the non-smoking participants. Char-
acteristics of participants with DMT2 and IGT did not differ except for
glycosylated hemoglobin A1c, intake of antidiabetic medication, and intake
of statins. Table 2 shows a description of the analyzed ECG parameters.
Spearman correlation coefficients between ECG parameters were calculated
for each ECG recording separately. According to the median of these corre-
lation coefficients all ECG parameters were uncorrelated (| r |< 0.5). HR,
RMSSD, and SDNN did not differ significantly between participants with
DMT2 or IGT (data not shown).
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Table 1: Description of the study population of 61 participants with type 2
diabetes or impaired glucose tolerance.
All Diabetes IGT p-value
(N=61) (N=31) (N=30)
Mean (SD) Mean (SD) Mean (SD)
Age (years) 65.7 (8.0) 66.7 (6.7) 64.8 (9.2) 0.37a
BMI (kg/m2) 30.2 (4.7) 30.9 (4.4) 29.5 (4.9) 0.27a
N (%) N (%) N (%)
Age (years)
≤ 60 14 (23) 6 (19) 8 (27) 0.50b
> 60 47 (77) 25 (81) 22 (73)
BMI (kg/m2)
≤ 30 32 (52) 15 (48) 17 (57) 0.52b
> 30 29 (48) 16 (52) 13 (43)
Gender
Male 40 (66) 23 (74) 17 (57) 0.15b
Female 21 (34) 8 (26) 13 (43)
Smoking
Never smoker 26 (43) 10 (32) 16 (53) 0.16c
Ex smoker 34 (58) 20 (65) 14 (47)
Occasional smoker 1 (2) 1 (3) 0 (0)
HbA1c
< 6.5% 46 (75) 17 (55) 29 (97) < 0.001c
≥ 6.5% 15 (27) 14 (45) 1 (3)
History of
Coronary heart disease 4 (7) 3 (10) 1 (3) 0.61c
Angina pectoris 5 (8) 2 (6) 3 (10) 0.67c
Myocardial infarction 6 (10) 5 (16) 1 (3) 0.20c
Hypertension 40 (66) 20 (65 20 (67) 0.86b
Medication use
Antidiabetics 18 (30) 17 (55) 1 (3) < 0.001c
β−blockers 18 (30) 11 (35) 7 (23) 0.30b
Statins 12 (20) 10 (32) 2 (7) 0.02c
IGT: impared glucose tolerance, SD: standard deviation, BMI: body mass index, HbA1c: glycosylated hemoglobin A1c,
β−blockers: Beta-adrenergic receptor blockers, aStudent’s t-test, bChi-square test, cFisher’s exact test
Table 2: Description of the 1h-averages of ECG parameters.
N Mean SD Min 25% Median 75% Max IQR
HR (beats/minute) 1153 79.3 14.5 46.5 69.3 78.9 87.9 132.9 18.7
RMSSD (ms) 1153 34.2 32.3 1.3 16.2 22.7 36.7 227.3 20.5
SDNN (ms) 1153 76.6 27.2 11.8 56.1 74.2 94.6 161.2 38.4
HR: heart rate, RMSSD: root mean square of successive differences in RR intervals, SDNN: standard deviation
of all normal RR intervals, SD: standard deviation, IQR: interquartile range
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Genotyping and influential SNPs
We identified 139 SNPs in the literature which are supposed to have an
influence on repolarization and HRV parameters. In our data, seven SNPs
were excluded either due to a MAF< 5% or an imputation quality< 0.6.
For 56 SNPs the hetero- and minor homozygous genotype were combined
to one group. Seven, eight, and ten SNPs did not have an additive effect
on HR, RMSSD, and SDNN, respectively, and therefore were not used for
the regression tree analysis. Seven, fourteen, and eleven SNPs were chosen
using the tree selection procedure for HR, RMSSD, and SDNN, respectively.
Supplemental Material, Table 1 contains information about the selected SNPs
such as the position, MAF, the authors who initially reported modulations of
ECG parameters by these SNPs, and their main effects on ECG parameters
estimated with mixed models in our study. The regression trees for HR,
SDNN, and RMSSD are given in the Supplemental Material, Figure 2.
Main effects of air pollutants
Figure 1 shows the percent changes of the mean ECG parameters per in-
terquartile range (IQR: difference between the third and first quartile) in-
crease in air pollutants together with 95%-confidence intervals (CI).
Increased BC levels were only marginally associated with an increase in
HR (percent change: 0.9%, 95%-CI: [0.0;1.8%]) with a lag of 6h. We observed
an association between increases in PM10 and PM2.5 and a concurrent reduc-
tion in RMSSD (-5.3% [-9.3;-1.1%] and -7.2% [-12.2;-1.8%], respectively).
Furthermore, RMSSD changed by -3.8% [-7.1;-0.5%] and -5.2% [-9.8;-0.4%]
in association with elevated BC levels with a lag of 1h and 6h, respectively.
Elevated PM2.5 level led to concurrent (-3.3% [-6.0;-0.7%]) and lagged de-
creases in SDNN by about 3-4%. We observed similar effects of PM10 and
sulfates. Increases in BC and UFP were only related with lagged decreases in
SDNN showing the strongest associations with a lag of 2h (-3.7% [-5.6;-1.8%]
and -1.9% [-3.4;-0.4%], respectively) .
Effect modification
We observed no significant air pollution effects on HR; therefore, we did not
calculate effect modifications by SNPs for this ECG parameter. As PM2.5
showed the strongest main effects on ECG parameters and PM variables were
highly correlated with BC and sulfate but uncorrelated with UFP, we only
present PM2.5 and UFP effect modifications by SNPs.
rs333229 was the strongest effect modifier on SDNN (Figure 2). 34 partici-
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Figure 1: Concurrent effects of 1h-averages of air pollutants on 1h-averages
on heart rate (HR), root mean square of successive differences in RR intervals
(RMSSD), and standard deviation of all normal RR intervals (SDNN).
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Figure 2: Effects of PM2.5 and UFP on SDNN modified by the number of
minor alleles of rs333229, rs2966762, and rs1871841. Interaction effects with
a p-value < 0.2 are indicated.
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pants with 651 SDNN intervals were homozygous carriers of the major allele,
23 participants with 429 SDNN intervals were heterozygous, and 4 partici-
pants with 73 SDNN intervals were homozygous carriers of the minor allele.
Throughout all lags only participants with at least one minor allele showed
a reduction in SDNN in association with increases in PM2.5. Individuals
with no minor allele did not react to elevated PM2.5 levels. We observed the
strongest modification with a lag of 4h (p-value of interaction=0.01). Par-
ticipants with one and two minor alleles exhibited a -6.6% [-10.3;-2.8%] and
a -12.9% [-20.6;-5.1%] decreased SDNN, respectively. PM2.5 effect modifica-
tion by rs2966762 resulted in a similar pattern with weaker effects (Figure 2).
Borderline and significant interaction effects between rs333229 and UFP on
SDNN were detected with a lag of 2h to 5h. SDNN decreased by about 2-3%
in individuals with one and about 4-6% in individuals with two minor alleles.
Furthermore, an increase in PM2.5 led to a 4-8% and to a 2-4% decrease in
SDNN in participants with no or one minor allele of rs1871841 (Figure 2).
The concurrent response of RMSSD to increases in PM2.5 was modified by
rs2096767 and rs2745967. Elevated PM2.5 levels led to a -10.0% [-15.5;-4.1%]
and a -13.2% [-23.3;-1.8%] reduction in RMSSD in individuals with one and
two minor alleles of rs2096767, respectively. In contrast, people with no (-
13.2% [-20.3;-5.6%]) and one minor allele (-6.4% [-11.5;-1.0%]) in rs2745967
exhibited a decrease in RMSSD in association with PM2.5. We observed no
effect modification by other SNPs selected with regression trees.
Analyzing air pollution effects on RMSSD and SDNN for participants with
D2TM and IGT separately showed that significant main and interaction ef-
fects were only observed in individuals with IGT. Figure 3 illustrates the
PM2.5 and UFP effect modification by rs333229 on SDNN in the two panels.
An increase in PM2.5 levels led to a 11-15% and to a 12-20% reduction in
SDNN in participants with IGT having one or two minor alleles of rs333229,
respectively. SDNN was reduced to a smaller amount (3-8%) in association
with increases in UFP with a lag of 2h to 5h in individuals with IGT with
at least one minor allele. We also observed effect modifications by rs2966762
and rs1871841 on SDNN only in participants with IGT (data not shown).
No significant air pollution effects and effect modifications by SNPs were
detected on SDNN and RMSSD in participants with DMT2.
Sensitivity analyses
There was no evidence for a deviation from linearity of the relationship be-
tween air pollutants and ECG parameters. Excluding 3 ECG recordings of
one occasional smoker and 17 ECG recordings of 14 participants who have
been exposed to ETS during the recording did not result in notable changes
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in the air pollution effects of both the main analysis and the interaction
analysis. The exclusion of 18 participants (66 ECG recordings) with an in-
take of beta-blockers and of 11 participants (37 ECG recordings) with CAD,
angina pectoris, or MI led to similar but less significant air pollution effects
on SDNN (data not shown).
DISCUSSION
Summary
We observed concurrent and lagged decreases in SDNN in association with el-
evated 1h-averages of PM and UFP levels in participants with metabolic dis-
orders and especially in individuals with at least one minor allele of rs333229.
Weaker effect modifications were observed for rs2966762 and rs1871841. A
reduction in RMSSD was only associated with concurrent PM increases.
These PM effects were stronger in individuals with at least one minor al-
lele of rs2096767 or at most one minor allele of rs2745967. In general, air
pollution effects seemed to be more pronounced in individuals with IGT than
with DMT2. We observed no air pollution effects on HR.
Air pollution and HRV
Previous studies assessed changes in HRV in association with air pollution ex-
posure calculated as 4h-, 6h-, or 24h-averages (Luttmann-Gibson et al. 2006;
Schneider et al. 2010). Zanobetti et al. (2010) observed a -1.5% [-2.5;-0.4%]
decrease in RMSSD but no changes in SDNN in association with elevated
1h-averages of PM2.5 directly preceding the ECG recording in patients with
CAD. In our study, we observed a concurrent reduction in RMSSD by -
6.8% [-11.7;-1.7%] and in SDNN by -3.3% [-5.8;-0.7%]. However, BC effects
were less pronounced in our study compared to the findings of Zanobetti et
al. Similar to our findings, a study conducted in taxi drivers in Beijing de-
tected a -2.2% [-3.8;-0.6%] reduction in SDNN in association with increases
in 30min-averages of PM2.5 measured inside the taxicab (Wu et al. 2010).
Furthermore, a study by Adar et al. (2007) showed that increases in 1h-
concentrations of traffic-related PM2.5 led to a decreased SDNN and RMSSD
in elderly participants. In contrast to our study, they also observed an in-
crease in HR associated with elevated PM2.5 levels. However, these studies
only reported the air pollution effects directly preceding the ECG recording.
Our findings of a rapid decrease in HRV in association with elevated PM-
levels might be mediated by a perturbation of the balance of the systemic
autonomic nervous system due to a stimulation of lung receptors or nerve end-
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ings in the human airways by inhaled particles (Brook et al. 2010). RMSSD
is an index of parasympathetic modulation, whereas SDNN reflects the vari-
ability of both sympathetic and parasympathetic activity. As we observed
a stronger reduction in SDNN than in RMSSD in association with PM in-
creases we assume that the activation of the sympathetic nervous system is
more pronounced than the vagal withdrawal. However, we did not find air
pollution effects on HR, an ECG parameter reflecting sympathetic activa-
tion. Additionally, we found a decrease in SDNN associated with elevated
UFP levels. A small fraction of UFP may pass alveolar walls and affect the
electric system of the heart directly (Peters et al. 2006) which might lead
to a reduced HRV. We detected concurrent and delayed PM effects but only
lagged UFP effects on SDNN. Therefore, we hypothesize that different effects
of PM and UFP might reflect different biological pathways activated by dif-
ferent particle properties. It has also been shown that a reduced HRV might
be a precursor of cardiovascular problems (Buccelletti et al. 2009; Lanza
et al. 2006; Reed et al. 2005). Hence, our observed findings might be an
intermediate step linking air pollution exposure to cardiovascular health.
Genotypes and susceptibility to air pollution
Susceptibility to air pollution exposure might be partly affected by genetic
predispositions as studies reported a modified HRV response by genotypes
of oxidative stress-related SNPs (Chahine et al. 2007; Probst-Hensch et al.
2008; Schwartz et al. 2005). It is assumed that inhaled PM induces oxida-
tive stress, an excess of reactive oxygen species, and a release of inflammatory
mediators in the lung which might lead to an imbalance of the autonomic
nervous system and hence to a decreased HRV (Brook et al. 2010). Thus,
it is hypothesized that people with a reduced oxidative defence due to ge-
netic predispositions might be especially susceptible to PM exposure. In our
study, we investigated possible air pollution effect modifications by SNPs in-
volved in changes of cardiac rhythm as reported in GWAS (Newton-Cheh et
al. 2007). We hypothesized that people with an altered HRV due to genetic
predispositions might also show different reactions to air pollution exposure.
We detected the strongest air pollution effects on SDNN in individuals with
at least on minor allele of rs333229 but no main effect of this SNP (Supple-
mental Material, Table 1). This SNP is located in the 3’untranslated region
of the choline transporter gene (CHT1 ) (Neumann et al. 2005). CHT1 en-
codes the high-affinity choline transporter (ChT) which carries choline into
acetylcholine (ACh)-synthesizing neurons. ACh is a neurotransmitter of the
sympathetic and parasympathetic system. Therefore, variations in CHT1
may account for variations in ACh neurotransmission which might lead to
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modulation of HR and HRV. However, we can only speculate that changes
in ChT affect the response to air pollution. rs2966762, rs1871841, rs2096767,
and rs2745967 modified the air pollution effects as well. Little is known about
biological pathways of these SNPs and their influence on the cardiovascular
system. rs2096767 is located in the matrix metallopeptidase 13 gene which
is involved in a wide variety of physiological and pathological processes, in-
cluding normal cell growth, differentiation, and cell regulation (Leeman et
al. 2002). Newton-Cheh et al. (2007) observed a significant modulation of
the PR-interval by rs2096767 in a GWAS. As all SNPs are located on differ-
ent chromosomes and are uncorrelated (data not shown) we assume that the
unknown underlying biological mechanisms could be different for each SNP.
Metabolic disorders and susceptibility to air pollution
The risk of developing CAD or suffering from an MI is increased in persons
with DTM2 (Beckman et al. 2002). It has also been shown that insulin re-
sistance might cause a reduction of the autonomic nervous system leading to
a reduced HRV in both DMT2 and IGT groups (Perciaccante et al. 2006).
Furthermore, authors reported QTc-prolongation, a marker of ventricular
arrhythmias, and a higher risk for emergency department visits and hospi-
tal admissions for individuals with DMT2 compared to individuals without
DMT2 in association with air pollution increases (Baja et al. 2010; Peel et
al. 2007; Zanobetti and Schwartz 2001). Therefore, we assumed that partic-
ipants with DMT2 or IGT might be especially susceptible to air pollutants.
However, we observed no air pollution effects in individuals with DMT2 - only
in IGT participants. By selecting subjects with IGT, we intended to study
the impact of air pollutants in subjects with an enhanced risk for DMT2
but who were not heavily treated by beta-blockers, statins, or anti-diabetic
medications as these medications may obliterate the effects of particle ex-
posures. In our study 81% of participants with DMT2 took beta-blockers,
statins, or anti-diabetic medication. These medications may have reduced
the possibility to detect ambient air pollution effects on ECG-parameters
for individuals with DMT2. People with diabetes are known to have dis-
proportional reactive oxygen species formation (Maritim et al. 2003) and we
speculate that this might be also true for individuals with IGT. PM has been
hypothesized to cause adverse health effects through the same mechanism.
Therefore, diabetes and PM may share common pathways and interact to
enhance responsiveness to air pollutants.
59
Strengths and limitations
A strength of our study is the ability to analyze intra-individual variation
in 1h-averages of ECG parameters measured repeatedly in up to four ECG
recordings with an average duration of 5.6h. Models were adjusted for long-
term time trend and meteorological variables to account for the possibility
that the detected associations resulted from meteorological influences or sea-
sonal differences alone. We controlled for circadian variation by design as the
repeated ECG recordings started at the same time (±2h) for each partici-
pant, respectively, and models were adjusted for time of day in case of model
fit improvement. A variety of outcome, exposure, and interaction variables
have been used in our analyses; thus, some associations may have occurred
only by chance. However, we reduced the number of performed tests by se-
lecting SNPs with regression trees in a prior step and we did not include all
139 SNPs as potential air pollution effect modifiers. Furthermore, regression
trees are not based on distributional assumptions. No additional tests were
carried out in the SNP selection process. Nevertheless, we did not adjust our
analyses for multiple testing as our analyses should be regarded as explo-
rative. A limitation of our study is that only one central measurement site
was used for the collection of ambient air pollution which poses a source for
exposure misclassification as it assumes homogeneous exposure for the whole
study area. Especially ultrafine particles are spatially heterogeneous and de-
pend on distance from the roadway as they are mostly produced by local
traffic. However, Cyrys et al. (2008a) investigated the temporal and spatial
variation of particle number concentrations (PNC) at four background sites
in Augsburg and reported high correlations (r > 0.80). Therefore, the use of
one single ambient monitoring site is an adequate approach for characterizing
exposure to ultrafine particles in time-series studies. A further strength of
this study is the investigation of air pollution effects in a particularly suscep-
tible subgroup. On the other hand, the results cannot be generalized to the
whole population.
Conclusion
We observed a reduced HRV, predominantly SDNN, in association with con-
current and delayed increases in 1h-averages of PM and UFP exposure. These
associations were modified by SNPs involved in cardiac rhythm. Therefore,
we identified persons with a genetic predisposition making them potentially
more susceptible to air pollutants with regard to HRV, a possible precursor of
cardiac adverse events. Moreover, as the prevalence of diabetes is increasing
worldwide it is important to conduct further investigations in this susceptible
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population.
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SUPPLEMENTAL MATERIAL
Methods
Genotyping
Genome-wide data were available for each individual. DNA was extracted
from ethylenediaminetetraacetic acid anticoagulated blood using a salting
out procedure. Given Affymetrix 6.0 genotyping, the whole set of genotypes
from HAPMAP release 22 were imputed with the Markov Chain Haplotype
(MACH) software package version 1.16 (Li et al. 2009). For our analysis
we only used SNPs supposed to be involved in cardiac rhythm (e.g. HR,
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RMSSD, high and low frequency, and PR- and QT-interval) which were al-
ready identified in the literature and published before August 2010. For the
selected SNPs, the allele dosages available from imputation were subsequently
transformed into best guess genotypes counting the number of minor alleles,
which is a typical coding if an underlying additive genetic effect model, i.e.
a constant increase per copy of the minor allele, is assumed. We tested for
evidence against the additive genetic model using a procedure introduced by
Schaid et al. (Schaid 2004). Thereby, we compared a model only including
a linearly coded SNP with a second model also including a variable indicat-
ing the heterozygous genotype. If the likelihood ratio test revealed a better
model fit (p-value¡0.1) of the second model we assumed that the respective
SNPs had no additive effect on the ECG-parameter. For our analysis we
excluded SNPs in case of 1) a minor allele frequency below 5%, 2) an impu-
tation quality (observed vs. expected variance of the genotypes as returned
as measure RSQR by MACH) below 0.6 potentially indicating a deviation
from Hardy-Weinberg equilibrium (HWE), or 3) a significant deviation from
the additivity assumption. If less than three participants with DMT2 or IGT
exhibited a homozygote minor allele frequency we combined the hetero- and
rare homozygous frequency of the respective SNP into one group.
Air pollution and meteorology data
Ambient air pollution and meteorological variables such as air temperature,
relative humidity, and barometric pressure were measured at a central mea-
surement site in Augsburg throughout the complete study period as described
previously (Cyrys et al. 2008; Pitz et al. 2008). Amongst others, hourly
means of particulate matter (PM) with an aerodynamic diameter below 10µm
or 2.5µm (PM10, PM2.5), ultrafine particles (UFP) with a size range of 0.01
to 0.1µm in diameter, and sulfate and black carbon (BC) mass concentra-
tion of PM2.5 were available. Particle mass concentrations of PM2.5 and
PM10 were measured by two separate Tapered Element Oscillating Microbal-
ance (TEOM, model 1400ab, Thermo Fisher Scientific Inc., USA) devices.
To correct the PM measurements for aerosol volatility effects, each TEOM
was equipped with a Filter Dynamics Measurement System (FDMS, model
8500b, Thermo Fisher Scientific Inc., USA). Particle size distributions (PSD)
in the range from 3-900 nm were measured by a custom-built Twin Differ-
ential Mobility Particle Sizer (TDMPS) system consisting of two cylindrical,
Vienna-type Differential Mobility Analyzers (DMA). Because of maintenance
or plausibility checks of the TEOM devices approximately 8% of the hourly
PM2.5 and PM10 values were missing. Single missing 1h-averages of PM
variables were replaced by the mean value of one hour before and after the
missing value. In case of longer time intervals with missing values, PM vari-
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ables were either replaced using a linear regression equation based on PSD
measurements of one day before and after the missing time period or if no
PSD measurements were available, the missing PM values were imputed by
the mean values of two other official urban background measurement sites.
The first one is located at the Bavarian Environment Agency approximately
3.5 kilometers south of the central measurement site and the second one is
located at the Bourgesplatz, about 2.5 kilometers north of central measure-
ment site. Missing values of all other air pollutants and of meteorological
variables were not replaced as less than 1% of the 1h-averages were missing
or no parallel measurements with other devices were available. Sulfate mea-
surements started on April 25th 2007 and the device for BC was under repair
between June 3rd and September 8th 2008.
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Supplemental Material, Table 1. SNPs which occurred in 75% of all regres-
sion trees performed for HR, SDNN, and RMSSD, respectively.
Known 
association to SNP %-change 95%-CI Chromosome Position Gene Major Minor MAF Coding Initial traits Publication
HR rs1801133 -1.9 (-9.0;4.8) 1 11778965 MTHFR G A 34 linear HF, LF, SDNN Baccarelliet al. 2008
rs2932529 -1.3 (-8.2;5.3) 1 112994887 CAPZA1 A G 30 linear RR Newton-Cheh et al. 2007
rs10494366 -4.7 (-11.7;1.3) 1 160352309 NOS1AP T G 33 linear QT
Arkinget al. 2006, 
Marroniet al. 2009, 
Lehtinenet al. 2008, 
Marjamaaet al. 2009, 
Postet al. 2007, Tobinet 
al. 2008
rs4657178 -1 (-8.7;6.5) 1 160477234 NOS1AP C T 24 linear QT Pfeufer et al. 2009
rs2745967 5.6 (0.0;12.3) 1 206195345 A G 36 linear RR Eijgelsheim et al. 2010
rs10495588 13 (5.5;23)* 2 12120724 G A 20 categorial QT Newton-Cheh et al. 2007
rs882300 2.8 (-3.6;9.8) 2 136692725 T C 34 linear PR Newton-Cheh et al. 2007
rs11970286 2.1 (-3.8;8.4) 6 118787067 PLN C T 35 linear QT Pfeufer et al. 2009, Eijgelsheim et al. 2010
rs757092 2.1 (-4.6;9.3) 11 2455754 KCNQ1 A G 34 linear QT Pfeufer et al. 2005
rs4488182 -6.6 (-16.2;1.6) 11 41032137 T G 22 categorial PR Newton-Cheh et al. 2007
rs2096767 -3 (-10;3.5) 11 102296609 MMP13 C G 30 linear PR Newton-Cheh et al. 2007
rs885389 -2.1 (-9.9;5.3) 12 130187715 GPR133 G A 28 linear RR Marroni et al. 2009
rs2074518 -9.6 (-16.9;-4.2)* 17 30348495 LIG3 C T 48 linear QT Newton-Cheh et al. 2009
rs1805127 3.8 (-1.6;9.9) 21 34743691 KCNE1 C T 37 linear T-wave alternans Koskela et al. 2008
RMSSD rs1801133 -4.8 (-25.6;21.8) 1 11778965 MTHFR G A 34 linear HF, LF, SDNN Baccarelli et al. 2008
rs12090585 4.3 (-17.8;32.4) 1 160305400 NOS1AP G A 28 linear QT Chambers et al. 2010
rs1932933 23.1 (-2.7;55.9) 1 160384670 NOS1AP C T 32 linear QT Chambers et al. 2010
rs1407709 58 (16;115.2) 1 186329302 C T 19 categorial TP Newton-Cheh et al. 2007
rs2745967 -21.4 (-36.7;-2.2) 1 206195345 A G 36 linear RR Eijgelsheim et al. 2010
rs1866559 5.3 (-15.6;31.5) 2 27189090 CGREF1 T C 38 linear SDNN Newton-Cheh et al. 2007
rs2643191 3.9 (-18.5;32.4) 3 165861387 C G 46 linear RR Newton-Cheh et al. 2007
rs10515199 -10.6 (-45.8;47.3) 5 74135390 C T 7 categorial TP Newton-Cheh et al. 2007
rs286751 7.7 (-14;34.9) 5 107430837 FBXL17 T C 44 linear SDNN Newton-Cheh et al. 2007
rs11970286 -9.9 (-27.5;11.9) 6 118787067 PLN C T 35 linear QT Pfeufer et al. 2009, Eijgelsheim et al. 2010
rs463924 0.2 (-21.7;28.1) 11 2674256 KCNQ1 C T 33 linear QT Pfeufer et al. 2005
rs2096767 18.9 (-5.9;50.4) 11 102296609 MMP13 C G 30 linear PR Newton-Cheh et al. 2007
rs3825214 -9.9 (-35.3;25.5) 12 113279826 TBX5 A G 20 categorial QRS, PR, QT Holm et al. 2010
rs1558139 -9.5 (-32.4;21.2) 19 15858564 CYP4F2 A G 43 linear QT Newton-Cheh et al. 2007
SDNN rs10494366 3.5 (-5.3;12.4) 1 160352309 NOS1AP T G 33 linear QT
Arking et al. 2006, 
Marroni et al. 2009, 
Lehtinen et al. 2008, 
Marjamaa et al. 2009, 
Post et al. 2007, Tobin et 
al. 2008
rs4669749 -8 (-17.4;1.5) 2 11610115 GREB1 A C 43 linear LF/HF Newton-Cheh et al. 2007
rs333229 -4.1 (-13.8;5.6) 2 107997816 CHT1 G T 25 linear HF Neumann et al. 2005
rs2966762 11.2 (2.9;19.5) 5 109411118 C T 44 linear SDNN Newton-Cheh et al. 2007
rs281868 5.9 (-2.3;14) 6 118680754 SLC35F1 A G 42 linear RR Eijgelsheim et al. 2010
rs1871841 -8.7 (-18.1;0.8) 8 13674417 C G 40 linear LF/HF Newton-Cheh et al. 2007
rs9297393 12.3 (3.8;20.7) 8 108356753 ANGPT1 T G 38 linear SDNN Newton-Cheh et al. 2007
rs10509700 6.8 (-1.6;15.3) 10 97884521 ZNF518 G C 43 linear LF/HF Newton-Cheh et al. 2007
rs4488182 13.8 (2.2;25.5) 11 41032137 T G 22 categorial PR Newton-Cheh et al. 2007
rs7188697 -9.2 (-22.0;3.6) 16 57179679 NDRG4 A G 18 categorial QT Pfeufer et al. 2009
rs17779747 3.2 (-6.0;12.4) 17 66006587 KCNJ2 G T 33 linear QT Pfeufer et al. 2009
HR: Heart rate, RMSSD: root mean square of successive differences in RR intervals, SDNN: standard deviation of all normal RR intervals, HF: high frequence, LF: low frequency, TP: total power, SNP: single nucleotide polymorphism, 
CI: confidence interval MAF: minor allele frequency; *SNP effects are still significant when using a Bonferroni adjusted p-value=0.05/14=0.00357. 
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Supplemental Material, Figure 1. 24h-averages of air pollutants and air tem-
perature measured during the study period from March 14th 2007 to Decem-
ber 17th 2008.
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Supplemental Material, Figure 2. Regression trees with the selected SNPs
for HR (beats/minute), RMSSD (ms), and SDNN (ms), respectively. The
mean values of the ECG parameter within each node are given below.
 
     HR 
|
rs10495588< 0.5
rs10494366>=1.5
rs2074518>=0.5
rs1805127< 0.5
rs885389< 0.5
rs1801133< 0.5
rs1801133>=0.5
rs1805127>=1.5
rs885389>=0.5
rs10494366>=1.5
rs2074518< 0.5
rs2745967< 0.5
rs2074518>=0.5
rs1805127>=1.5
rs2745967< 1.5
rs1801133< 0.5
63.83
54.45 70.53
74.72
72.8 85.07
75.85 87.48
62.23
64.86 84.53
76.94
67.9
87.8 106.6
95.24 114.5
 
 
 
    RMSSD* 
|
rs1932933< 1.5
rs1407709< 0.5
rs3825214>=0.5
rs10515199>=0.5
rs1558139>=0.5
rs2643191>=1.5
rs286751< 1.5
rs2096767< 1.5
rs1801133< 0.5
rs1866559< 1.5
rs2643191< 1.5
rs11970286< 0.5
rs2643191< 0.5
rs463924< 0.5
1.755
2.655 3.163
2.445
2.963 3.601
3.655
3.026
3.668 4.559
3.243
3.604 4.654
3.564 4.391
 
*rs12090585 and rs2745967 appear in 75% of all conducted trees always excluding a single ECG recording. 
 These SNPs do not appear in this tree using all ECG recordings. 
 
 
     SDNN 
|rs2966762< 1.5
rs1871841>=1.5
rs333229< 0.5 rs7188697>=0.5
rs10509700< 0.5 rs281868< 1.5
rs10494366< 0.5
rs17779747>=0.5
rs4669749>=1.5
rs9297393< 1.5
rs4488182< 0.5
39.76 67.54
58.55 71.38
55.41 72.52
80.34
35.87
90.7 112.8
77.91 103.6
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